Next Article in Journal
Underrecognized Tick-Borne Encephalitis in Serbia: Evidence from Patients with Suspected West Nile Virus Neuroinvasive Disease
Previous Article in Journal
Campylobacter spp. in Poultry Slaughterhouses: Occurrence, Antimicrobial Resistance, and Virulence-Associated Genes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Current Insights into the Epidemiology and Transmission Dynamics of African Swine Fever Virus and Future Control Perspectives

by
Shanta Barua
1,
Asep Gunawan
2,
Autchara Kayan
3,
Masa Tenaya
4,
Mehmet Ulas Cinar
5,
Made Kardena
4,
Syeda Hasina Akter
1,
Nurulfiza Mat Isa
6,
Henry Annandale
1,
Subir Sarker
7,8,
David T. Williams
9,
Sam Abraham
10,11 and
Jasim M. Uddin
1,11,12,*
1
School of Veterinary Medicine, Murdoch University, Perth, WA 6150, Australia
2
Department of Animal Production and Technology, Faculty of Animal Science, IPB University, Bogor 16680, Indonesia
3
Department of Animal Science, Faculty of Agriculture, Kasetsart University, Bangkok 10900, Thailand
4
Faculty of Veterinary Medicine, Udayana University, Bali 80234, Indonesia
5
Department of Animal Science, Faculty of Agriculture, Erciyes University, 38280 Kayseri, Türkiye
6
Department of Cell & Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia
7
School of Biomedical Sciences & Molecular Biology, College of Medicine and Dentistry, James Cook University, Townsville, QLD 4814, Australia
8
Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, QLD 4811, Australia
9
CSIRO Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
10
School of Medical, Molecular and Forensic Sciences, Murdoch University, Perth, WA 6150, Australia
11
Centre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Perth, WA 6150, Australia
12
Centre for Animal Production and Health, Food Future Institute, Murdoch University, Perth, WA 6150, Australia
*
Author to whom correspondence should be addressed.
Pathogens 2026, 15(6), 586; https://doi.org/10.3390/pathogens15060586 (registering DOI)
Submission received: 1 May 2026 / Revised: 22 May 2026 / Accepted: 26 May 2026 / Published: 29 May 2026
(This article belongs to the Section Viral Pathogens)

Abstract

African swine fever virus (ASFV) is an evolving threat to global swine health and food security, driven by its complex epidemiology, multi-host transmission cycles, and ongoing spread across countries. This review summarizes the global scenario and transmission pathways of ASFV, highlighting the outbreaks associated with evolving risk patterns to support effective disease prevention and control. ASF has been reported in pig-producing regions across Africa, Europe, and, more recently, Asia, largely driven by the spread of genotype II strains. The virus is transmitted through direct contact with infected pigs or pig-products, indirectly via contaminated materials, and through soft ticks of the genus Ornithodoros spp., with epidemiological patterns varying according to wildlife reservoirs and regional factors. Control measures mainly rely on early detection, movement control, strict quarantine, robust biosecurity measures, and international trade regulations. Despite significant advances, persistent challenges, including the absence of a widely available commercial vaccine, long-term stability of the virus, human activities, and inconsistencies in global response capacities, continue to hinder disease eradication efforts. This review underscores the need for transnational strategies and policies that integrate economically sustainable disease management systems and reduce the long-term impact of ASFV.

1. Introduction

African swine fever (ASF) is a contagious and devastating transboundary viral disease of domestic and wild pigs that impacts global pig production, international pork trade, agricultural economics, and social stability in affected regions [1,2,3]. The disease is caused by African swine fever virus (ASFV), an enveloped, double-stranded DNA virus, and is the sole member of the genus Asfivirus and family Asfarviridae, responsible for outbreaks of severe hemorrhagic disease, with mortality rates reaching up to 100% depending on the virulence of the strain [4,5]. ASFV possesses a complex multilayered virion structure and a genome of approximately 170–190 kb, encoding more than 150 viral proteins that contribute to viral replication, host interaction, and immune evasion [6,7]. Unlike many other DNA viruses, ASFV replicates primarily in the cytoplasm of infected cells, especially in monocytes and macrophages, which play a role in viral dissemination and pathogenesis [8].
Historically, the virus was first described in Kenya in the early 1920s and was largely confined to sub-Saharan Africa for several decades by maintaining a complex sylvatic transmission cycle involving wild suids such as warthogs and soft ticks of the genus Ornithodoros [9]. However, over the past two decades, the virus has emerged as one of the most significant transboundary diseases that threatens pig production and food security globally [10,11]. The World Organization for Animal Health (WOAH) recognizes ASF as one of the most severe transboundary animal diseases due to its rapid spread and significant threat to pig populations across international borders [12]. The introduction of genotype II into Georgia in 2007 marked the beginning of a major panzootic, which subsequently expanded across Eastern Europe, Russia, and large parts of Asia, resulting in huge economic losses in the global pork industry [11,13,14]. Since then, outbreaks of ASFV have been recorded in several countries of Europe and Asia, and more recently in Southeast Asia, the Pacific and the Caribbean, showing the ability of the virus to rapidly disseminate across continents through complex epidemiological pathways [10,15,16]. ASFV transmission occurs through multiple pathways, including direct contact between infected and susceptible pigs, indirectly through contaminated fomites and pork products, wildlife reservoirs such as wild boar, and biological vectors such as soft ticks [9,10,11,17,18].
The global spread of the virus has resulted in substantial economic losses to the swine industry, including the disruption of pork production, restrictions in international pork trade, and significant financial losses both in commercial and smallholder pig production [11]. Despite extensive research efforts, the disease continues to pose major challenges to the global pork production due to the absence of widely available safe and effective vaccines and the complex epidemiology involving domestic pigs, wildlife reservoirs, vectors, and long-time environmental persistence of the virus [11,15]. Therefore, a comprehensive understanding of the virus biology, epidemiological patterns and determinants, and transmission pathways is essential to improve and implement prevention and control strategies. This review aims to summarize the current global scenario, transmission mechanisms, and insights into the pathobiology of ASFV, highlighting the existing challenges and recent advances that may guide future research and disease control efforts.

2. Virus Structure, Genome and Strains

ASFV is a large, complex DNA virus measuring approximately 200 to 300 nm in diameter [4,6,19]. The virion exhibits a highly organized, multi-layered architecture, including the outer envelope, capsid, inner envelope, core shell, and nucleoid. These layers contain approximately 151–167 open reading frames (ORFs) that encode around 150–200 viral proteins (about 68 structural proteins and more than 100 non-structural proteins) [4,19,20,21]. The complex structure of the virus leads to environmental stability and long-term persistence in the contaminated environment and animal products, which plays vital role in virus transmission and epidemiology. The structural components of the ASFV, including proteins and their functions, are summarized in Figure 1 and Table 1.
ASFV shows significant genetic variation and evolutionary flexibility. The genome is a large linear double-stranded DNA molecule characterized by covalently closed ends that form inverted terminal repeats (ITRs) [19,20]. Many ASFV genes form multigene families (MGFs) that are arranged in tandem arrays [48,49] and play important roles in virulence, host range determination, host adaptation, and immune modulation [50,51]. Certain ASFV proteins also exhibit host-like genetic fragments; for example, the A238L protein suppresses NF-κB signaling through motifs resembling host IκB proteins, thereby contributing to virus survival and immune evasion [52,53]. The genome is organized structurally into a conserved central core region (CCR) flanked by variable regions (VR) on both terminal ends [54], where gene insertions, deletions, duplications, and mutations occur frequently [46,54,55]. These genetic changes determine the differences in virulence, transmission dynamics, and host adaptation among virus strains. The loss or acquisition of certain genomic segments and repeated sequences are responsible for strain diversity and viral evolution over time [55]. In contrast, the CCR remains conserved and is often used as an epidemiological marker for genotype differentiation of ASFV isolates [56,57]. Several genome sequence analyses have identified single-nucleotide polymorphisms (SNPs) and gene rearrangements that are useful for tracing the origin and evolution of specific outbreaks [57,58]. Arrangement of the genomic structure of ASFV is shown in Figure 2.
ASFV isolates have traditionally been classified into 24–25 genotypes based on sequence variation in the C-terminal region of the B646L gene encoding the p72 capsid protein [59,60]. However, recent genomic re-evaluation has suggested that these historical genotypes can be consolidated into six major p72 groups, emphasizing the need for more robust whole-genome-based classification approaches [60]. Among these, genotype II is considered the most significant as it is responsible for the major global outbreaks that started in Georgia in 2007 and subsequently spread across Europe and Asia [61]. In addition, molecular markers such as the O174L gene have been used to distinguish closely related strains and to track the origin of outbreaks, such as those reported in Poland [62]. Recent genomic research continues to reveal emerging ASFV variants and regional lineages. For instance, genome sequencing of ASFV outbreaks in West Africa revealed two main viral lineages circulating in Nigeria, indicating that the virus is still evolving and diversifying in different regions [58]. In Europe, a multigene typing approach has identified at least 26 distinct variants of genotype II ASFV [63,64]. In addition, several countries have reported variants with genetic deletions or reduced virulence, proving that ASFV continues to adapt to changes in the interfaces between its environment and host populations [65,66]. This high level of genetic variation creates challenges for vaccine development, accurate diagnosis, and effective disease control [67].

3. Pathobiology, Transmission, and the Global Situation

3.1. Pathobiology of ASFV

Primary replication of the virus starts in the macrophages of the oropharyngeal region, including tonsils and regional lymph nodes [67,68]. The virus subsequently spreads to key organs, including the spleen, bone marrow, liver, lungs, and kidneys through the bloodstream, causing viremia [69,70]. Despite primary viral replication in the macrophages, infection of endothelial cells and other cell types has also been observed [68,70]. Although the precise host receptors remain incompletely defined, the virus enters host cells through different pathways, including micropinocytosis, clathrin-mediated endocytosis (CME), phagocytosis, involvement of Fc-receptor, apoptotic mimicry, and utilization of apoptotic bodies [71]. A distinctive feature of the virus is that it replicates within specialized ‘viral factories’ in the cytoplasm of the infected cells [50,68]. Viral structural proteins contribute to attachment to the host cell surface and promote uptake into the target cell, whereas viral genomic nucleic acid can alter macrophage phagocytic activities, further influencing the host defense mechanism for successful replication [67]. Many proteins of the virus manipulate host cellular pathways to facilitate viral replication and spread by suppressing antiviral interferon responses [72,73].
ASFV evades the host defense mechanisms in different ways. It applies immunomodulatory strategies to evade early host defenses to establish infection and promote disease [68]. These mechanisms include suppressing the signaling of type I interferon (IFN), modulating antigen presentation, and interfering with cytokine networks. Recent studies indicate that infection with ASFV activates cytoplasmic DNA-sensing mechanisms, including the cGAS-STING pathway, leading to downstream signaling that may simultaneously amplify proinflammatory responses while limiting effective antiviral immunity [40,74]. ASFV also interferes with how infected macrophages process and present antigens, which makes it harder for the adaptive immune system to become fully activated. Additionally, the virus leads to the reduced production of cytokines by altering the NF-κB and JAK-STAT signaling pathways [75,76]. This weakens the host antiviral defenses and contributes to immune dysregulation and facilitates systemic disease progression.
Infected macrophages produce high levels of proinflammatory cytokines, including IL-1, IL-6, TNF-α, driving severe systematic inflammation and tissue injury through contributing to a cytokine storm [50,77]. Inflammatory mediators such as TNF-α and IL-1β exaggerate acute ASF disease by causing vascular injury, tissue edema, and organ dysfunction [69]. The virus initially inhibits apoptosis in infected cells to allow viral replication; however, later, extensive apoptosis of uninfected lymphocytes through immune signaling results in lymphoid depletion and immune collapse [41,70]. Moreover, the virus causes pathological changes in the vascular endothelium. Endothelial dysfunction, platelet abnormalities, and coagulation cascade disturbances lead to disseminated intravascular coagulation (DIC), as well as widespread hemorrhage observed in acute infection [68,69]. Since ASFV affects the key innate immune cells in pigs, it causes significant changes in the host immune response and pathobiological changes, leading to severe disease outcomes and high mortality.

3.2. Transmission Mechanisms

ASFV transmission is multifaceted, including direct and indirect transmission across farm environments, between domestic and wild pig populations, and via arthropod vectors. The primary route of transmission is direct contact between infected and susceptible pigs through oro-nasal contact or contaminated bodily fluids, respiratory secretions, and excreta containing high viral loads [78,79]. In addition, field investigation suggested that short distance airborne spread through droplets or contaminated dust may infect pigs in adjacent piggeries even without direct contact [12]. These observations show the importance of environmental factors and housing conditions in the spread of the virus.
Indirect transmission plays a major role in the epidemiology of ASF. Contaminated fomites such as farm equipment, vehicles, clothing, footwear, and veterinary instruments serve as mechanical carriers, facilitating virus transmission between pens and farms [12]. Unrestricted personnel movement between premises without adequate disinfection and biosecurity measures exacerbate virus dispersal [80]. Moreover, the virus remains infective for prolonged periods in raw or uncooked pork products, enabling infection of naïve herds through contaminated swill feed or water [81,82].
The disease dynamics could be further complicated by the involvement of wild suids in the epidemiological landscape of ASF. In many parts of Europe and Asia, wild boar populations act as significant reservoirs, maintaining ongoing viral circulation in the environment and serving as infection sources for neighboring domestic pig herds through overlapping habitats, shared water bodies or feed sources, especially in backyard or outdoor production systems or low-biosecurity settings [83,84,85]. In addition, carcasses of infected wild boar contribute to local transmission cycles via environmental contamination and scavenging by other wild boar or interaction with virus-contaminated soil and vegetation [86].
In endemic regions of sub-Saharan Africa, vector-mediated transmission has been well documented. The sylvatic transmission cycle is maintained, where soft-ticks (genus: Ornithodoros) interact with wildlife reservoir hosts, such as warthogs (Phacochoerus africanus), bushpigs (Potamochoerus larvatus), red river hogs (Potamochoerus porcus), and giant forest hogs (Hylochoerus meinertzhangeni), and facilitate virus circulation between wild suids and domestic pigs [87,88]. Soft ticks such as O. moubata complex in Africa and O. erraticus in Europe acquire the virus during blood feeding and subsequently transmit it through bites, maintaining long-term tick–pig transmission cycles through transstadial and transovarial transmission [5]. The virus replicates in various organs and body parts of the ticks and persists in a viable state for extended periods, ranging from 23 to 239 days, depending on the species. Even longer survival times have been documented, reaching up to 3 years in O. moubata, 5 years in O. erraticus, and over 500 days in O. coriaceus [79,89,90]. The first investigation of localization of ASFV in O. porcinus was conducted by Rock [89], showing that the virus multiplies primarily in hemocytes (types I and II), followed by secondary replication sites such as tissues in the midgut epithelium, phagocytic cells, connective tissues, salivary glands, coxal glands, and reproductive organs. The peak viral titers were recorded after 91 days of infection in the salivary glands and reproductive tissues [90]. Consequently, infected ticks can potentially act as long-term reservoirs by protecting the virus from environmental stress and sources of reinfection, whereas long-distance transmission is mediated indirectly through the movement of hosts carrying infected ticks and contaminated materials [79]. In addition, virus survival in the ticks, even in the absence of hosts, complicates the eradication process. These features make ASFV a unique DNA arbovirus transmitted by arthropod vectors [91]. Moreover, mechanical transmission by certain hematophagous insects, such as the stable flies (Stomoxys calcitrans), has been demonstrated experimentally, although their epidemiological significance in natural outbreaks is less studied [92].
The complex transmission dynamics of ASFV highlight the importance of adopting integrated perspectives targeting direct contact, environmental stability, and indirect spread via vectors, fomites, and wildlife-livestock interfaces. Effective control strategies therefore require coordinated biosecurity, surveillance, monitoring, and management practices to mitigate virus spread within and between pig populations. The different transmission dynamics of ASFV are illustrated in Figure 3.

3.3. History and Global Distribution

Although ASF outbreaks have been occurring since 1909, the virus was first formally documented in 1921 as a severe, highly fatal hemorrhagic disease affecting pigs owned by European settlers in Kenya, East Africa [68,93,94,95]. Comparable cases have also been observed earlier in Zambia’s Eastern Province since 1912 [96]. During the late 1920s and early 1930s, reports of ‘East African swine fever’ were noted in the north-eastern regions of South Africa, and subsequently confirmed the disease in Angola and Malawi [97,98]. By the mid-1990s, the disease persisted as a wildlife-associated (sylvatic) infection across much of eastern and southern Africa, extending into the southern Central Africa [99]. Its maintenance in these regions was linked to a natural transmission cycle involving warthogs and Ornithodoros ticks [9,17].
From 1930 to 1950, the virus persisted endemically in sub-Saharan Africa, where multiple genotypes evolved and circulated between domestic pigs and wildlife, periodically causing severe outbreaks in smallholder systems [98,100]. In the late 1950s, the virus spread into Europe and West Africa, marking its first transcontinental incursions [10]. ASFV persistence in Africa is primarily driven by wildlife–domestic interfaces rather than trade networks. In the future, risk mitigation efforts in Africa should therefore focus on controlling wildlife–livestock interfaces, strengthening smallholder biosecurity, and enabling early detection in high-risk ecological zones.
In Europe, ASFV was first detected in Portugal in 1957, likely introduced through contaminated pork products [10,101]. Although the initial outbreak was rapidly controlled, a reintroduction in 1960 led to sustained transmission across the Iberian Peninsula, particularly in Portugal and Spain, where the disease persisted for more than three decades and demonstrated significant transboundary and long-distance dissemination [102,103]. Outbreaks were also reported in several western [10,17,101,103] and eastern European countries [104] (Table S2), but eradication programs successfully eliminated the virus by the mid-1990s. However, ASF remained endemic on the island of Sardinia, following its introduction in 1978, for more than four decades, until intensive eradication and biosecurity programs led to official declaration of being ASF free in 2024 [105,106,107]. Thus, situations in Europe indicate remarkable epidemiological adaptability and transboundary transmission potential of the virus, emphasizing the importance of biosecurity and eradication programs to mitigate the risk of future outbreaks and endemic persistence.
In 2007, genotype II of ASFV was introduced into Georgia through contaminated pork products [4,13]. This pivotal epidemiological shift marked the beginning of the contemporary Eurasian panzootic. The virus established an endemic cycle in wild boar and domestic pigs and spread across the Russian Federation and Eastern Europe from the Caucasus [108]. It subsequently reached the Baltic States, Poland, Germany, and other European Union countries, where factors such as wild boar density, carcass persistence, and human-mediated movements contributed significantly in viral spread [109,110]. However, the dominant transmission pathways varied regionally; wildlife-driven transmission and environmental persistence predominated in eastern Europe, whereas human-mediated activities such as illegal pork trade, contaminated vehicles, and fomites were considered to initiate new outbreaks in western Europe [111]. Phylogenetic analysis confirms that most recent European outbreaks are linked to genotype II lineages derived from the 2007 introduction, and these strains have gradually diversified due to repeated transboundary movement [112]. Overall, ASFV persistence and expansion in Europe reflects a complex interplay between wildlife ecology and anthropogenic factors.
In 2018, the epidemiological landscape changed dramatically with the confirmation of ASFV in the world’s largest pig population, China [113,114]. As a result of the long-distance transport of pigs and pork products, weak biosecurity, and the complex production network, the virus spread extensively across Chinese provinces within months [115]. The virus subsequently expanded across east and southeast Asia, including Vietnam, where widespread outbreaks from 2019 to 2024 resulted in substantial herd losses and restructuring of the pig farming sector [116]. Similar genotype II outbreaks were reported in the Philippines, Indonesia, Timor-Leste and other parts of the region [70,117]. Whole-genome sequencing of the virus in Indonesia revealed close relatedness to other Asian genotype II strains, indicating regional connectivity [16]. South Asia experienced its first confirmed outbreak in India in 2020, which further expanded southward contributing to the Asian epidemic spread including Nepal and Sri Lanka [113,118,119]. Therefore, ASFV control in Asia cannot rely solely on biosecurity; instead, it requires strengthened regional trade surveillance, border security enforcement, and coordinated transboundary monitoring systems to establish effective regional containment.
Since its first description, ASF has persisted in Africa for more than a century through the complex interface of wildlife reservoirs, tick vectors, and low-biosecurity pig production systems [9,58,120]. In contrast, the Americas remained largely ASF-free after extensive eradication efforts in the 1980s. However, re-detection in the Dominican Republic and Haiti in 2021 highlighted the propensity for ASFV to re-emerge and emphasized the importance of robust surveillance systems and effective control measures [121]. Although the United States is still ASF-free, modelling studies suggest that an outbreak could cause major economic losses due to the large pig industry and export market of the country [122]. Therefore, strengthening cross-border surveillance, improving biosecurity in smallholder systems, and enhancing regional collaboration remain critical for preventing further spread of ASFV.
To date, Australia remains free from ASFV; however, its proximity to Southeast Asia, strong international trade connections, and presence of the virus in northern neighboring countries, including Timor-Leste, western Indonesia and Papua New Guinea, create a persistent incursion risk [16,123,124]. Economic assessments estimate that a small-scale outbreak of ASFV in Australia could result in losses of $117–263 million in domestic pigs, with eradication in feral pigs costing approximately $101–127 million, whereas endemic establishment could incur around $0.4–2.5 billion [125]. Risk assessments and fuzzy modelling approaches identified possible pathways, including illegal pork import, swill feeding, contaminated fomites, and international passenger movement [126]. Within Australia, higher outbreak risk is predicted in regions with high-pig density and a large overlapping population of feral pigs [127,128]. In addition, temperature and rainfall patterns could influence the virus survivability and spatial spread [129]. Although direct Australian evidence remains limited, international studies suggest that vehicles used in livestock transport, shared equipment, and long-distance pig movements could facilitate farm to farm transmission [130]. This emphasizes the importance of strict cleaning and disinfection protocols and effective traceability systems to reduce transmission risk [131].
As of 2025–2026, continuous circulation and sporadic new outbreaks have been reported in domestic pigs and wild boar across parts of eastern Europe, southeast Asia, and sub-Saharan Africa [95,132]. Nearly 2000 cases were detected both in domestic pigs and wild boar over 16 European between January and February 2026 [133]. The UK has also been identified as high-risk due to human-mediated pathways, wild boar movements, and non-commercial pork imports [133]. Genotype II remains the dominant ASFV strain circulating across Eurasia, although whole-genome and multi-gene sequencing studies are now showing increasing genetic variation [63,64,112]. Despite advances in genomic epidemiology and outbreak modelling, the disease remains difficult to eradicate once established in wild pig populations, especially in areas with inconsistent biosecurity and limited cross-border coordination [68]. Global distribution and sequential outbreaks of ASFV are shown in Figure 4 and Supplementary Table S1.
ASFV infection in pigs can occur simultaneously with other viral infections, especially where multiple swine diseases circulate. For instance, one of the earliest cases of co-infection of ASFV with porcine circovirus type-2 (PCV-2) was documented in pigs from Indonesia and Mongolia [134]. As PCV-2 infection can induce immunosuppression, such co-infections may elevate disease severity through increasing susceptibility to secondary pathogens during ASF outbreaks. In West Africa, genomic screening of pigs in Nigeria revealed that ASFV-infected pigs frequently harbored multiple viral agents simultaneously, including PCV-2, PCV-3, and porcine parvovirus-1 (PPV-1), with nearly half of the sampled pigs testing positive for two or more pathogens [135]. Additionally, diagnostic studies have shown the possibility of concurrent infection of ASFV with classical swine fever virus (CSFV) in endemic regions, emphasizing the importance of multiplex molecular assays to differentiate these clinically similar infections [136]. These findings suggest that ASF outbreaks often occur in complex pathogen environments, complicating clinical diagnosis, surveillance, and control strategies in affected pig populations.

4. Key Determinants of ASFV Epidemiology

A key determinant in ASF epidemiology is the remarkable environmental stability of ASFV, which enables prolonged survival in pork products, carcasses, and contaminated fomites [8,105]. Persistence of the virus in organic materials, including blood and tissues, enhances exposure through contaminated equipment, clothing, vehicles, feed, and water, contributing significantly to farm-to-farm spread [1].
Lack of biosecurity and management practices are major risk factors for ASF outbreaks in both commercial and backyard production systems. Epidemiological investigation in the Philippines demonstrated that the absence of perimeter fencing, poor visitor control measures, insufficient vehicle disinfection, and limited quarantine protocols significantly increased the risk of virus introduction into domestic pig farms [137]. Swill feeding, particularly the use of improperly treated food waste containing infectious pork products, remains a historically documented and epidemiologically significant risk factor, especially in smallholder or backyard systems [138]. Furthermore, a lack of biosecure feed sourcing, inadequate carcass disposal, deficiencies in cleaning and disinfection, improper manure and effluent management, and environmental contamination of water sources are linked to higher disease outbreaks [1,138,139,140].
Host population and husbandry practices also increase disease transmission risk [141]. High pig density accelerates virus spread once introduced within the herd. In smallholder or backyard farming systems, pigs are often reared under low input conditions with limited confinement and biosecurity, particularly in free-roaming pig systems, which increases the probability of contact with neighboring herds or wildlife [140,141]. Virus amplification and transmission may also be facilitated by mixed production systems where animals of different ages and health status are reared without strict segregation rules or practices [142].
Governance factors and socio-economic conditions also contribute substantially to the risk of ASF. Prolonged outbreak duration and wider dissemination of the virus have been noted in regions with limited veterinary infrastructure, delayed reporting systems, and insufficient compensation schemes. The transmission pathways are also influenced by informal trade networks and pig slaughter and pork distribution practices [80,143]. Global ASF studies further emphasize that farmer awareness, monitoring systems, and compliance with control measures strongly influence epidemic outcomes [1].
The risk profile of ASF reflects the complex interactions of several factors, including viral persistence, host density, wildlife ecology, farm biosecurity, socio-economic conditions, and trade networks. For designing evidence-based control programs and further preventing geographical expansion of the disease, a comprehensive understanding of the interconnection of these risk factors is essential. Therefore, an integrated approach combining strengthened biosecurity, controlled animal movement, wildlife management, improved surveillance systems, and community engagement are required for effective mitigation strategies of the disease. The key determinants that influence ASFV dissemination are demonstrated in Figure 5.

5. ASFV Control and Management Strategies

The dissemination of ASF can be controlled only through the prompt detection and implementation of standard disease management practices, such as ongoing surveillance, epidemiological assessments, tracing of pig movements, stamping out of infected populations, enforcing biosecurity protocols, applying quarantine measures, and the regulation of animal movement [144].

5.1. Infection Management and Containment

Once an outbreak of ASF occurs, infection management becomes challenging. In an ideal scenario, outbreak containment relies on rapid diagnosis and immediate notification to the veterinary authorities to enable emergency response activities [8,145]. Following confirmation, movement restrictions on pigs are enforced, and zoning systems comprising infected, surveillance, and protection zones are established to prevent further disease spread [145]. Furthermore, safe carcass disposal, the destruction of contaminated animal products, thorough cleaning and disinfection of infected premises, restriction of the movement of farm personnel and contaminated equipment, and epidemiological tracing systems should be implemented to identify infection sources and guide targeted interventions [145]. Since commercially available vaccines are limited, a combination of these measures is essential for rapid containment to prevent regional spread [8]. However, due to the high pathogenic nature of the virus and its severe economic impact, stamping out at the herd level remains the preferred strategy in ASF-free countries.

5.2. Culling and Depopulation

Culling and depopulation are widely used control measures to limit the transmission of ASFV once detected in domestic pig populations. The rapid removal of infected animals and separating exposed pigs can help halt within-and between-farm spread [2], whereas whole-herd depopulation has traditionally been applied to quickly eliminate infection sources and reduce further dissemination risk [146]. However, this approach may lead to major economic losses, particularly in large commercial pig industries and in countries with limited or no compensation.
Socio-economic conditions and farming practices are key considerations in the implementation of culling and depopulation. Recent studies emphasized alternative approaches such as selective or partial culling [147,148,149]. Studies conducted in Vietnam showed that partial culling involving removal of only infected and high-risk contact animals and selective culling in combination with strict monitoring, quarantine of affected pens, and improved hygiene measures act as potential effective approaches for managing ASF outbreaks [116,147,148]. Similar studies in China reported that precise culling, along with regular testing and strict movement control, helped to eliminate the virus while protecting unaffected pigs [149]. These findings suggest that targeted depopulation strategies may be effective when early detection systems and strong biosecurity are applied.
In wildlife populations, culling has also been used to reduce disease reservoirs. For example, in Europe, intensive carcass removal combined with hunting has been suggested as an effective strategy to reduce virus persistence in wild boar populations [150]. Furthermore, targeted culling of infected wildlife population can slow down the spread of the disease, although the success rate depends on population density, surveillance capacity, and landscape factors [151]. Overall, culling and depopulation remain essential components of ASF outbreak control; however, this should be applied very carefully and together with other control strategies.
Cost sharing is critical for effective culling or depopulation during ASF outbreaks as it distributes the financial burden between government and industry, enabling rapid response and compliance. For instance, in Animal Health Australia’s Emergency Animal Disease Response Agreement (EADRA), the costs of the outbreak response, including culling and compensation, are jointly funded with the aim of improving early reporting and timely eradication [152,153]. Although private livestock insurance exists, government compensation schemes are the primary mechanisms to support depopulation and helps farmers restock rather than rely solely on insurance [152]. For example, Australia provides compensation (market-value payment) for animals destroyed under official disease control and cost is shared under the EADRA framework. In contrast, in endemic regions of Africa and Asia, the lack of compensation has led to emergency sales and the informal slaughtering of infected pigs locally by small holders or the improper disposal of infected carcasses, leading to under-reporting and ‘silent spread’ of the virus into the market value chain [154,155,156]. Nevertheless, prevention is better as depopulation is impossible for many countries considering the economic condition of the farmer and the lack of financial support or insurance.

5.3. Vaccination

ASF vaccine development has been a high priority for decades but has gained further impetus in the last 20 years with the emergence of ASFV in Europe and Asia. Although first generation vaccines have recently been commercialized, their approval and use are limited to certain countries. Therefore, disease control still largely relies on strict biosecurity, surveillance, and the culling of infected animals. However, the rapid global spread of the disease since the late 2000s has increased the importance of developing effective vaccines capable of protecting domestic pigs and wild suids against multiple ASFV genotypes [8,15].
Currently, live-attenuated vaccines (LAVs) represent the most promising approach for inducing protective immunity. Some LAV candidates, such as HLJ/18-7GD [157], appear to be safe for pregnant sows without noticeable effects on reproduction or offspring health [158]. Nevertheless, safety concerns remain with LAVs, including potential reversion to virulence, persistent infection, and recombination risk with field strains [159,160]. Regular monitoring of vaccine strains and the development of genetic safeguards are therefore important to reduce the risk of virulence reversion and to ensure the long-term safety of LAVs.
Alternative approaches, including viral-vectored, subunit, DNA, and mRNA vaccines, are also under investigation to improve safety and stability. For example, replication incompetent adenovirus-vectored vaccines expressing five immunogenic ASFV antigens have provided partial protection in pigs [161,162], and multi-antigen strategies using adenovirus and modified vaccinia Ankara vectors have shown protection against lethal challenge [162,163]. However, some studies using similar adenovirus vectors carrying ASFV genes failed to protect pigs when they were exposed to virulent genotype II strains, showing the difficulty to identify optimal antigen combinations [163]. More recent approaches using multicistronic cassettes spanning the entire ASFV Georgia 2007/1 proteome have shown promising protection, suggesting that multi-antigen formulations may enhance immune responses [164]. Advances in immuno-informatics and antigenic design multi-epitope vaccines and the use of purifying recombinant viruses such as CRISPR/Cas9 gene editing and efficient cloning systems are also accelerating ASF vaccine development [165,166,167]. These findings suggest that vectored vaccines are promising, but ASF immunization research is still developing. Despite these advances, most subunit vaccines still provide only partial or inconsistent protection, particularly against genotype II strains [168,169,170,171,172]. Integrating multi-antigen targets and improved delivery technologies such as nanoparticle-based platforms may enhance the effectiveness of subunit-based vaccines.
In wild suids, oral bait vaccine formulations containing gene-deleted ASFV strains have shown promising immune responses and acceptable environmental safety [173]. However, some approaches, such as the attenuated NH/p68 strain grown in MA104 cells, failed to provide sufficient protection, suggesting that vaccine formulation and delivery remain major challenges [174]. Therefore, future research should focus on optimizing bait formulations, improving vaccine stability in field conditions, and combining wildlife vaccination with effective surveillance and population management strategies.
Despite significant progress, a universally effective ASF vaccine is currently unavailable. Large-scale vaccination programs must consider cross-protection between virus genotypes, vaccine production capacity, and regulatory approval processes [175,176]. In this regard, the first ASF vaccine standards were recently adopted as part of the WOAH Terrestrial Manual in recognition of the development and commercialization of the first-generation ASF vaccine and for the purpose of providing minimum standards for safe and effective vaccines [177]. Importantly, vaccination alone cannot control ASF due to its complex transmission cycle; therefore, integrated strategies combining vaccination, strong biosecurity, surveillance, and wildlife management remain essential for effective disease control [3,68]. A detailed list of ASFV vaccines is given in Supplementary Table S2.

5.4. Biosecurity Measures

In the absence of a widely available and effective ASFV vaccine, control strategies heavily rely on the strict biosecurity implementation at farm, animal, and individual (personnel) levels.
At the farm level, biosecurity aims to prevent virus introduction through structural and management-based measures, including the separation of clean and dirty zones, controlled entry points, and perimeter fencing systems [178]. For instance, pig farms in Germany commonly implement designated hygiene barriers (anterooms) and farm zoning systems, although gaps in fencing and area separation still exists [178]. Double fencing systems are widely used in the European Union to minimize contact between domestic pigs and wild boar [81], whereas commercial farms in countries such as China [179] and the United States practice controlled feed supply chains, risk assessment scoring systems, and structured programs such as the Secure Pork Supply Plan to enhance biosecurity compliances [180]. Strong biosecurity and border controls underpin Australia’s prevention strategy for ASFV and other emerging animal diseases. Australian piggeries implement robust on-farm measures, including effective fencing, strict visitor and personnel protocols, surveillance and control of wild pig populations, and stringent feed regulations with a prohibition on swill feeding [181]. These are complemented by mandatory property registration and tight controls on animal movements to minimize the risk of disease introduction and spread.
At the animal level, biosecurity practices mainly focus on reducing disease transmission within and between pig groups through age or production stage segregation and batch management. Spot elimination approaches have also helped to reduce losses and protect farmer livelihoods [116]. In major pig-producing countries, the structured disposal of carcass and storage systems for manure management are commonly practiced [180].
At the individual level, human-mediated transmission could be mitigated through hygiene protocols such as dedicated farm-specific clothing and footwear, handwashing, the use of disinfectant footbaths, and controlled movement of staff between farm units [178,180,182,183]. High-biosecurity farms further implement strict entry protocols, including shower-in/shower-out systems, restricted access systems, visitor restriction, controlled access logs, and supervised entry procedures to reduce indirect transmission through visitors, veterinarians, and transport workers [178,184]. Despite these measures, ASFV continues to spread due to a lack of synchronization among farmers, government, public, and even nations to follow the precautionary measures systematically.

6. Major Challenges and Future Directions

6.1. Animal Movement

Animal movement is one of the major causes of ASF spread across regions and production systems. Long-distance dissemination of the virus can be facilitated by the movement of infected pigs and trade of live pigs, even before infected pigs begin showing clinical symptoms [185]. Furthermore, the virus may be introduced into previously disease-free areas through illegal trade and the uncontrolled movement of pigs, including movements associated with breeding or market supply chains, if proper biosecurity and quarantine are not maintained [186]. Higher risk of spread exists in the regions where pig production involves constant transport between farms, markets, and slaughterhouses [100]. In many developing countries, informal trade networks and live animal markets further increase the disease transmission chances as animals often move without proper health inspection [156]. Improving traceability systems, using digital identification for pigs, and applying movement permits can help authorities to better trace and detect outbreaks earlier. During an outbreak, combining real-time surveillance with movement control measures can also help to reduce the spread of disease.

6.2. Illegal Meat and Meat Products

The illegal trade and transportation of pork and pork products are major drivers of transboundary ASFV spread. Due to the environmental stability of ASFV, contaminated meat can remain infectious for prolonged periods [105]. The genetic material of ASFV is detected in illegally imported meat products, indicating the potential for virus introduction through travelers carrying contaminated pork and pork products, informal markets, and unregulated food trade [187,188]. Nevertheless, imported pork products may bypass veterinary inspection systems in several regions [189]. Domestic pigs and wild suids can become infected through the consumption of contaminated products that are improperly disposed or used as swill [190]. Therefore, improving border monitoring, food import regulations, public awareness campaigns, and rapid screening methods for imported animal products could reduce these risks since diagnostics are limited to risk-based inspections without ASFV specific testing. For example, in Australia, pork and pork products entering through airports or cargo channels undergo strict biosecurity controls administered by the Department of Agriculture, Fisheries and Forestry under the Imported Food Inspection Scheme. Meat products must be declared and screened using X-ray imaging, detector dogs, and manual baggage inspection [191]. Fresh pork is prohibited, whereas only certain processed products from approved countries are permitted with appropriate certification. In addition, commercial consignments undergo risk-based inspection and samples are tested for microbial contamination, chemical residues, and compliance with Australian food standards. On the other hand, non-compliant or undeclared items are seized and destroyed to prevent the introduction of exotic and economically important animal diseases such as ASF [192].

6.3. Human Movement

Farm workers, veterinarians, traders, and visitors can unintentionally spread ASFV on clothing, footwear, or farm equipment [78]. Additionally, international travel and labor migration, including backpackers or seasonal agriculture workers, may facilitate virus introduction through contaminated materials, food items or farm materials across borders [185]. A study in Asia demonstrated that the human-mediated movement of pigs, feed, and contaminated materials contributed to the rapid regional spread of the disease following virus introduction [115]. Significant reduction of such transmission requires robust training programs promoting hygiene protocols and on-farm biosecurity, strict visitor control policies, and raising awareness among travelers regarding contaminated animal products. In addition, farm-level biosecurity training programs for all personnel involved in pig production is also required. Effective control of ASFV depends on continuous and practical biosecurity training that improves farmers knowledge, attitudes, and compliance behaviors [178]. Similarly, community-based biosecurity programs in endemic regions such as Uganda demonstrated that awareness alone is insufficient unless training is adapted to socio-economic contexts and reinforces daily practices across the value chain [193]. Several countries and organizations have implemented structured awareness initiatives, including FAO-led training and e-learning programs for farmers, veterinarians, paraprofessionals, and hunters in Europe (2020–2025) that improved early detection, reporting, on-farm hygiene measures, and biosecurity in wild boar interfaces [194]. Likewise, Australia’s ASF prevention and preparedness project (initiated in 2020) reported that coordinated stakeholder engagement, training, and public awareness campaigns strengthen surveillance, early detection, and response capacity [195]. Therefore, integrated awareness strategies combining farm worker training, community engagement, and stakeholder education remain among the most effective non-pharmaceutical interventions for ASFV control.

6.4. Biosecurity Standards

Effective biosecurity implementation remains highly challenging due to structural, economic, behavioral, and epidemiological constraints. In farms, limitations in infrastructure, farm design, and financial capacity often hinder measures such as controlled entry points, sanitation barriers, and separation of clean and contaminated zones [105,196]. The complex epidemiology of ASFV further complicates control as the virus can persist in contaminated materials and the environment, whereas indirect transmission through fomites, feed, and human movement amplifies disease spread [8,11]. Control of wild and feral pig movement remain challenging due to their wide-ranging behavior and ability to cross diverse landscapes. Measures such as fencing and population control are difficult to implement at scale and are only partially effective. Therefore, coordinated surveillance and cross-border collaboration are essential. Emerging technologies, including AI-driven computer vision integrated with CCTV surveillance, may improve tracking of wild pig movement, whereas engagement of the hunting communities can support control efforts. Countries such as Australia have a dedicated feral pig control program [197]. Nevertheless, strategies should be tailored to regional geography and aligned with local environmental, cultural, and socio-economic conditions.
At the national level, biosecurity implementation is further challenged due to the lack of harmonized and enforceable standards. Although farms should adhere to standardized biosecurity protocols audited by national accreditation or veterinary authority, uniform compliance across diverse production systems may not be feasible, particularly among smallholder and backyard farms [198]. Economic barriers also discourage outbreak reporting and compliance with stamping-out policies when cost-sharing or compensation schemes are inadequate [199].
To overcome these challenges, strategies must be locally adapted, economically feasible, and socially inclusive. Biosecurity measures must be cost effective and context-specific, in combination with participatory approaches for smallholder farmers to adopt them with local practices and priorities [193,200]. Economic barriers can be addressed through fair compensation and cost sharing schemes for culled animals to encourage disease reporting and compliance. Future efforts should emphasize community-based biosecurity programs, interdisciplinary approaches integrating social and economic factors, and digital surveillance systems for sustainable ASF control.

6.5. Strict Border Security

The global spread of ASF over the past two decades highlights how international trade, weak border control, and inadequate monitoring systems have contributed to its rapid transboundary spread [201]. Strengthening border surveillance, the use of detector dogs for meat products, and increasing international collaboration on disease monitoring can enhance early detection and the prevention of ASF. All pork-producing countries should follow standardized biosecurity procedures formulated by international bodies such as the WOAH, with a strong focus on transboundary animal diseases. For instance, implementing strict biosecurity protocols at airports and seaports, supported by quarantine screening and robust enforcement measures are essential. These measures may include fines, visa cancellation, and deportation for failing to declare illegal meat and meat products. However, many countries still lack effective airport biosecurity programs, creating global gaps in ASFV prevention and control efforts.

6.6. Genetic Improvement of Pigs

Advanced technologies, including high-throughput genome sequencing and gene editing, are enabling the identification of candidate genes and the development of disease-resistant farm animals [202]. For instance, the porcine reproductive and respiratory syndrome virus (PRRSV) enters porcine cells via the CD163 receptor; accordingly, pigs genetically modified using CRISPR/Cas9 to delete CD163 exhibit resistance to PRRSV [203,204]. Although all wild-type pigs succumbed to infection, 75% of CD163Mut/Mut pigs survived and recovered, establishing a strong foundation for breeding PRRSV-resistant pigs through gene-editing technologies [205]. Furthermore, macrophages from genome-edited pigs lacking the CD163 SRCR5 domain are fully resistant to both American and European PRRSV genotypes while maintaining normal biological function [206]. Although CD163 plays a role in the permissiveness and infection process of porcine monocytes/macrophages by ASFV [207], pigs lacking CD163 did not exhibit resistance to the ASFV isolate Georgia 2007/1 [208]. Nevertheless, several studies have identified key host genes regulating ASFV permissiveness, including SLA-DM [209] and CRISPR/Cas9-edited germlines have been developed to evaluate the roles of these candidate genes [210]. A CRISPR/Cas9 knockout study also identified TMEM239 as an important host factor facilitating ASFV entry into early endosomes [211]. Encouragingly, multiple research groups are working to identify genes associated with ASFV infection and host tolerance [212]. Comparative genomic studies further indicate that genetic variation among pig breeds influences ASFV infection rates [213,214]. Understanding the function of host genes is crucial, and advanced biotechnology such as CRISPR/Cas9 may help unravel their roles. For instance, CRISPR/Cas9-mediated editing has identified that the T-cell receptor beta (TRBV27) CDR1 sequence is associated with ASFV infection in pigs [215]. The application of advanced breeding technologies based on gene editing holds strong promise to transform the pig industry by improving animal health and productivity [216].

6.7. Policy Development and Implementation

Effective policy frameworks are essential for ASF control and preparedness. However, many countries face difficulties implementing coordinated control strategies due to limited resources, inconsistent regulations, and weak enforcement mechanisms [217]. Furthermore, differences in national disease control policies, reporting systems, and compensation schemes may hinder rapid outbreak responses and cooperation between stakeholders [218]. In some regions, insufficient policy guidance for smallholder pig systems further complicates disease control efforts [156]. Therefore, policy makers should focus on developing coordinated international policies, better compensation schemes, and stronger One Health-based surveillance systems, integrated risk assessment frameworks, and emergency preparedness plans to enhance ASF prevention and outbreak responses.

6.8. Global Coordination

Global coordination is critical for effective ASF control as the disease spreads across national borders and requires harmonized international action. Existing global bodies such as the World Organization for Animal Health (WOAH), Food and Agriculture Organization (FAO), and Global Framework for the Progressive Control of Transboundary Animal Diseases (GF-TADs) provide a foundation for standards setting, coordinated global monitoring, outbreak reporting, and response systems, enabling countries to share surveillance data and align control strategies. The Global African Swine Fever Research Alliance (GARA) is an international network established in 2013 which brings researchers together to generate knowledge and practical solutions to monitor and control ASF worldwide [219]. Ongoing support for research networks such as GARA will be critical for information sharing, fostering collaboration and the identification of knowledge and technological gaps for supporting the prevention, control, and eradication of ASF. Since ASF transmission patterns vary across regions due to differences in socio-economic conditions, husbandry practices, trade activities, border control, and biosecurity practices, strong, multifaceted collaborations between government and private sectors are needed to enforce biosecurity across the value chain. The major challenges for prevention and control of ASF globally are summarized in Figure 6.

7. Conclusions

The evolving challenges of ASFV are reflected in its expanding global epidemiology, persistent transboundary spread, recurrent outbreaks, and a complex multi-host transmission cycle involving domestic pigs, wild boar, and human-mediated pathways. Epidemiological evidence suggests that indirect transmission through contaminated fomites, pork products, and the movement of infected animals plays a dominant role in long-distance spread, whereas wild boar populations serve as long-term wildlife reservoirs that sustain endemicity in several regions. A deeper understanding of ASFV biology, particularly host–virus interaction and immune evasion mechanisms, is essential to support rational vaccine design. However, the development and deployment of vaccines requires robust post-vaccination safety and efficacy monitoring, including surveillance for adverse effects, field effectiveness, and potential virus evolution under immune pressure. Until safe and widely effective vaccines are achieved, control strategies must prioritize the strengthening of disease management and risk-based surveillance systems, early detection, and strict on-farm biosecurity. Critical measures include minimizing contact between wild and domestic pigs, banning swill feeding, vector control in specific ecological settings where soft ticks contribute to transmission cycles, regulating animal movement, carcass removal, and reinforcing border biosecurity. Importantly, these interventions must be economically feasible and practically applicable, requiring strong coordination among governments, private sectors, farmers, and veterinarians. Sustained progress depends on effective policy implementation and international coordination and data sharing among veterinary authorities, WOAH, FAO, researchers, and the livestock industry to ensure harmonized outbreak reporting, and cross-border control. Overall, a coordinated approach integrating enhanced surveillance, strict farm biosecurity and border security, structured wild boar management, cautious vaccine development and monitoring, and strong international collaboration is required to mitigate the global impact of ASFV on pig health and the livestock industry.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/pathogens15060586/s1, Table S1. Chronological summary of ASFV outbreaks worldwide [4,8,10,13,17,68,94,95,97,98,100,101,103,105,109,110,111,113,116,117,122,125,133,220,221,222,223,224,225,226,227,228,229,230,231,232,233,234,235,236,237]; Table S2. List of ASFV vaccines with their types, strain used, developers and manufacturers (where relevant), efficacy, side effects and limitations [158,161,165,168,170,172,238,239,240,241,242,243,244,245,246,247,248,249,250,251,252,253,254,255,256,257].

Author Contributions

Conceptualization, S.B. and J.M.U.; data curation, S.B. and J.M.U.; writing—original draft preparation, S.B. and J.M.U.; writing—review and editing, S.B., J.M.U., A.G., A.K., M.T., M.U.C., M.K., S.H.A., N.M.I., H.A., S.S., D.T.W. and S.A.; visualization, S.B.; supervision, J.M.U. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study.

Acknowledgments

We acknowledge the funding support of a Murdoch International Postgraduate Scholarship (MIPS) awarded to S.B.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Bergmann, H.; Dups-Bergmann, J.; Schulz, K.; Probst, C.; Zani, L.; Fischer, M.; Gethmann, J.; Denzin, N.; Blome, S.; Conraths, F.J. Identification of risk factors for African swine fever: A systematic review. Viruses 2022, 14, 2107. [Google Scholar] [CrossRef] [PubMed]
  2. Ceruti, A.; Kobialka, R.M.; Abd El Wahed, A.; Truyen, U. African swine fever: A one health perspective and global challenges. Animals 2025, 15, 928. [Google Scholar] [CrossRef]
  3. Ranganatha, S.; Rathnamma, D.; Isloor, S.; Hiremath, J.; Chandranaik, B. African swine fever: Analysing its epidemiology, pathogenesis and control strategies: A review. Indian J. Anim. Res. 2020, 1, 567–576. [Google Scholar] [CrossRef]
  4. Li, Z.; Chen, W.; Qiu, Z.; Li, Y.; Fan, J.; Wu, K.; Li, X.; Zhao, M.; Ding, H.; Fan, S. African swine fever virus: A review. Life 2022, 12, 1255. [Google Scholar] [CrossRef] [PubMed]
  5. Ruedas-Torres, I.; Thi to Nga, B.; Salguero, F.J. Pathogenicity and virulence of African swine fever virus. Virulence 2024, 15, 2375550. [Google Scholar] [CrossRef]
  6. Wang, Y.; Kang, W.; Yang, W.; Zhang, J.; Li, D.; Zheng, H. Structure of African swine fever virus and associated molecular mechanisms underlying infection and immunosuppression: A review. Front. Immunol. 2021, 12, 715582. [Google Scholar] [CrossRef] [PubMed]
  7. Mazloum, A.; van Schalkwyk, A.; Chernyshev, R.; Igolkin, A.; Heath, L.; Sprygin, A. A guide to molecular characterization of genotype II African swine fever virus: Essential and alternative genome markers. Microorganisms 2023, 11, 642. [Google Scholar] [CrossRef]
  8. Dixon, L.K.; Sun, H.; Roberts, H. African swine fever. Antivir. Res. 2019, 165, 34–41. [Google Scholar] [CrossRef]
  9. Penrith, M.L.; Kivaria, F.M. One hundred years of African swine fever in Africa: Where have we been, where are we now, where are we going? Transbound. Emerg. Dis. 2022, 69, e1179–e1200. [Google Scholar] [CrossRef]
  10. Sánchez-Vizcaíno, J.; Mur, L.; Gomez-Villamandos, J.; Carrasco, L. An update on the epidemiology and pathology of African swine fever. J. Comp. Pathol. 2015, 152, 9–21. [Google Scholar] [CrossRef]
  11. Blome, S.; Franzke, K.; Beer, M. African swine fever–A review of current knowledge. Virus Res. 2020, 287, 198099. [Google Scholar] [CrossRef]
  12. Juszkiewicz, M.; Walczak, M.; Woźniakowski, G.; Podgórska, K. African swine fever: Transmission, spread, and control through biosecurity and disinfection, including polish trends. Viruses 2023, 15, 2275. [Google Scholar] [CrossRef] [PubMed]
  13. Rowlands, R.J.; Michaud, V.; Heath, L.; Hutchings, G.; Oura, C.; Vosloo, W.; Dwarka, R.; Onashvili, T.; Albina, E.; Dixon, L.K. African swine fever virus isolate, Georgia, 2007. Emerg. Infect. Dis. 2008, 14, 1870. [Google Scholar] [CrossRef]
  14. Zhou, X.; Li, N.; Luo, Y.; Liu, Y.; Miao, F.; Chen, T.; Zhang, S.; Cao, P.; Li, X.; Tian, K. Emergence of African swine fever in China, 2018. Transbound. Emerg. Dis. 2018, 65, 1482–1484. [Google Scholar] [CrossRef]
  15. Urbano, A.C.; Ferreira, F. African swine fever control and prevention: An update on vaccine development. Emerg. Microbes Infect. 2022, 11, 2021–2033. [Google Scholar] [CrossRef]
  16. O’Dwyer, J.; Van, H.V.; Phuong, N.T.; Mileto, P.; Mercado, O.; Conceição, F.d.; Jong, J.B.d.C.; Puana, I.; Neave, M.J.; Williams, D.T. Emergence of Microvariants of African Swine Fever Virus Genotype II in the Asia–Pacific. Transbound. Emerg. Dis. 2025, 2025, 9990044. [Google Scholar] [CrossRef] [PubMed]
  17. Costard, S.; Wieland, B.; De Glanville, W.; Jori, F.; Rowlands, R.; Vosloo, W.; Roger, F.; Pfeiffer, D.U.; Dixon, L.K. African swine fever: How can global spread be prevented? Philos. Trans. R. Soc. B Biol. Sci. 2009, 364, 2683–2696. [Google Scholar] [CrossRef]
  18. Bernard, J.; Vial, L.; Madeira, S.; Otte, J.; Boinas, F.; Le Potier, M.-F.; Jourdan-Pineau, H. Experimental design impacts the vector competence of Ornithodoros ticks for African swine fever virus: A meta-analysis of published evaluations. Peer Community J. 2025, 5, e58. [Google Scholar] [CrossRef]
  19. Galindo, I.; Alonso, C. African swine fever virus: A review. Viruses 2017, 9, 103. [Google Scholar] [CrossRef]
  20. Venkateswaran, D.; Prakash, A.; Nguyen, Q.A.; Salman, M.; Suntisukwattana, R.; Atthaapa, W.; Tantituvanont, A.; Lin, H.; Songkasupa, T.; Nilubol, D. Comprehensive characterization of the genetic landscape of African swine fever virus: Insights into infection dynamics, immunomodulation, virulence and genes with unknown function. Animals 2024, 14, 2187. [Google Scholar] [CrossRef] [PubMed]
  21. Yang, S.; Miao, C.; Liu, W.; Zhang, G.; Shao, J.; Chang, H. Structure and function of African swine fever virus proteins: Current understanding. Front. Microbiol. 2023, 14, 1043129. [Google Scholar] [CrossRef]
  22. Jia, N.; Ou, Y.; Pejsak, Z.; Zhang, Y.; Zhang, J. Roles of African swine fever virus structural proteins in viral infection. J. Vet. Res. 2017, 61, 135. [Google Scholar] [CrossRef]
  23. Pérez-Núñez, D.; García-Belmonte, R.; Riera, E.; Fernández-Sesma, M.H.; Vigara-Astillero, G.; Revilla, Y. Signal peptide and N-glycosylation of N-terminal-CD2v determine the hemadsorption of African swine fever virus. J. Virol. 2023, 97, e01030-23. [Google Scholar] [CrossRef]
  24. Vuono, E.A.; Ramirez-Medina, E.; Pruitt, S.; Rai, A.; Espinoza, N.; Velazquez-Salinas, L.; Gladue, D.P.; Borca, M.V. Evaluation of the function of the ASFV KP177R gene, encoding for structural protein p22, in the process of virus replication and in swine virulence. Viruses 2021, 13, 986. [Google Scholar] [CrossRef]
  25. Muñoz, A.; Tabarés, E. Characteristics of the major structural proteins of African swine fever virus: Role as antigens in the induction of neutralizing antibodies. A review. Virology 2022, 571, 46–51. [Google Scholar] [CrossRef]
  26. Liu, Q.; Ma, B.; Qian, N.; Zhang, F.; Tan, X.; Lei, J.; Xiang, Y. Structure of the African swine fever virus major capsid protein p72. Cell Res. 2019, 29, 953–955. [Google Scholar] [CrossRef]
  27. Wei, S.; Lu, P.; Miyata, T.; Makino, F.; Namba, K.; Liu, C.; Niu, Y.; Saito, S.; Okuda, S.; Tsutsumi, K. African swine fever virus protein pB602L is a unique molecular chaperone promoting the folding of the major capsid protein p72 and the polyprotein processing protease pS273R. Int. J. Biol. Macromol. 2026, 347, 150685. [Google Scholar] [CrossRef] [PubMed]
  28. Zhou, P.; Li, L.-F.; Zhang, K.; Wang, B.; Tang, L.; Li, M.; Wang, T.; Sun, Y.; Li, S.; Qiu, H.-J. Deletion of the H240R gene of African swine fever virus decreases infectious progeny virus production due to aberrant virion morphogenesis and enhances inflammatory cytokine expression in porcine macrophages. J. Virol. 2022, 96, e01667-21. [Google Scholar] [PubMed]
  29. Huang, L.; Liu, H.; Ye, G.; Liu, X.; Chen, W.; Wang, Z.; Zhao, D.; Zhang, Z.; Feng, C.; Hu, L. Deletion of African swine fever virus (ASFV) H240R gene attenuates the virulence of ASFV by enhancing NLRP3-mediated inflammatory responses. J. Virol. 2023, 97, e01227-22. [Google Scholar] [CrossRef] [PubMed]
  30. Cui, S.; Wang, Y.; Gao, X.; Xin, T.; Wang, X.; Yu, H.; Chen, S.; Jiang, Y.; Chen, Q.; Jiang, F. African swine fever virus M1249L protein antagonizes type I interferon production via suppressing phosphorylation of TBK1 and degrading IRF3. Virus Res. 2022, 319, 198872. [Google Scholar] [CrossRef]
  31. Zheng, W.; Xia, N.; Zhang, J.; Cao, Q.; Jiang, S.; Luo, J.; Wang, H.; Chen, N.; Zhang, Q.; Meurens, F. African swine fever virus structural protein p17 inhibits cGAS-STING signaling pathway through interacting with STING. Front. Immunol. 2022, 13, 941579. [Google Scholar] [CrossRef] [PubMed]
  32. Suárez, C.; Gutiérrez-Berzal, J.; Andrés, G.; Salas, M.L.; Rodríguez, J.M. African swine fever virus protein p17 is essential for the progression of viral membrane precursors toward icosahedral intermediates. J. Virol. 2010, 84, 7484–7499. [Google Scholar] [CrossRef]
  33. Aicher, S.-M.; Monaghan, P.; Netherton, C.L.; Hawes, P.C. Unpicking the secrets of African swine fever viral replication sites. Viruses 2021, 13, 77. [Google Scholar] [CrossRef]
  34. Galindo, I.; Viñuela, E.; Carrascosa, A.L. Characterization of the African swine fever virus protein p49: A new late structural polypeptide. J. Gen. Virol. 2000, 81, 59–65. [Google Scholar] [CrossRef]
  35. Alonso, C.; Miskin, J.; Hernáez, B.; Fernandez-Zapatero, P.; Soto, L.; Cantó, C.; Rodríguez-Crespo, I.; Dixon, L.; Escribano, J.M. African swine fever virus protein p54 interacts with the microtubular motor complex through direct binding to light-chain dynein. J. Virol. 2001, 75, 9819–9827. [Google Scholar] [CrossRef]
  36. Anggy, F.P.; Nugroho, W.S.; Irianingsih, S.H.; Enny, S.; Srihanto, E.A. Genetic analysis of African swine fever viruses based on E183L (p54) gene, circulating in South Sumatra and Lampung province, Indonesia. Vet. World 2023, 16, 1985. [Google Scholar] [CrossRef] [PubMed]
  37. Rodríguez, J.M.; Salas, M.L. African swine fever virus transcription. Virus Res. 2013, 173, 15–28. [Google Scholar] [CrossRef]
  38. Vuono, E.; Ramirez-Medina, E.; Silva, E.; Rai, A.; Pruitt, S.; Espinoza, N.; Valladares, A.; Velazquez-Salinas, L.; Gladue, D.P.; Borca, M.V. Deletion of the H108R gene reduces virulence of the pandemic Eurasia strain of African swine fever virus with surviving animals being protected against virulent challenge. J. Virol. 2022, 96, e00545-22. [Google Scholar] [CrossRef]
  39. Matamoros, T.; Alejo, A.; Rodríguez, J.M.; Hernáez, B.; Guerra, M.; Fraile-Ramos, A.; Andrés, G. African swine fever virus protein pE199L mediates virus entry by enabling membrane fusion and core penetration. mBio 2020, 11, 10–1128. [Google Scholar] [CrossRef]
  40. Luo, J.; Zhang, J.; Ni, J.; Jiang, S.; Xia, N.; Guo, Y.; Shao, Q.; Cao, Q.; Zheng, W.; Chen, N. The African swine fever virus protease pS273R inhibits DNA sensing cGAS-STING pathway by targeting IKKε. Virulence 2022, 13, 740–756. [Google Scholar] [CrossRef]
  41. Tian, C.; Liu, Y.; Di, D.; Xie, Z.; Li, Y.; Wang, R.; Li, J.; Liu, J.; Chen, H. Immunogenicity and efficacy of an LNP-mRNA prepared from African swine fever virus K205R1. J. Integr. Agric. 2024, 24, 4026–4033. [Google Scholar] [CrossRef]
  42. Alejo, A.; Matamoros, T.; Guerra, M.; Andrés, G. A proteomic atlas of the African swine fever virus particle. J. Virol. 2018, 92, 10–1128. [Google Scholar] [CrossRef]
  43. Fu, D.; Zhao, D.; Zhang, W.; Zhang, G.; Li, M.; Zhang, Z.; Wang, Y.; Sun, D.; Jiao, P.; Chen, C. Structure of African swine fever virus p15 reveals its dual role for membrane-association and DNA binding. Protein Cell 2020, 11, 606–612. [Google Scholar] [CrossRef]
  44. Freitas, F.B.; Frouco, G.; Martins, C.; Ferreira, F. The QP509L and Q706L superfamily II RNA helicases of African swine fever virus are required for viral replication, having non-redundant activities. Emerg. Microbes Infect. 2019, 8, 291–302. [Google Scholar] [CrossRef]
  45. Duan, X.; Ru, Y.; Yang, W.; Ren, J.; Hao, R.; Qin, X.; Li, D.; Zheng, H. Research progress on the proteins involved in African swine fever virus infection and replication. Front. Immunol. 2022, 13, 947180. [Google Scholar] [CrossRef]
  46. Chen, S.; Wang, T.; Luo, R.; Lu, Z.; Lan, J.; Sun, Y.; Fu, Q.; Qiu, H.-J. Genetic variations of African swine fever virus: Major challenges and prospects. Viruses 2024, 16, 913. [Google Scholar] [CrossRef]
  47. Istrate, C.; Marques, J.; Bule, P.; Correia, S.; Aires-da-Silva, F.; Duarte, M.; Reis, A.L.; Machuqueiro, M.; Leitão, A.; Victor, B.L. In Silico characterization of African swine fever virus nucleoprotein p10 interaction with DNA. Viruses 2022, 14, 2348. [Google Scholar] [CrossRef]
  48. Nunes-Correia, I.; Rodríguez, J.M.; Eulálio, A.; Carvalho, A.L.; Citovsky, V.; Simões, S.; Faro, C.; Salas, M.L.; de Lima, M.C.P. African swine fever virus p10 protein exhibits nuclear import capacity and accumulates in the nucleus during viral infection. Vet. Microbiol. 2008, 130, 47–59. [Google Scholar] [CrossRef] [PubMed]
  49. Torma, G.; Tombácz, D.; Csabai, Z.; Moldován, N.; Mészáros, I.; Zádori, Z.; Boldogkői, Z. Combined short and long-read sequencing reveals a complex transcriptomic architecture of African swine fever virus. Viruses 2021, 13, 579. [Google Scholar] [CrossRef] [PubMed]
  50. Zhang, D.; Zhang, S.; Yang, F.; Zhu, Z.; Zheng, H. Host-pathogen interactions in African swine fever: From viral entry to systemic disease progression. Cell Insight 2025, 5, 100297. [Google Scholar] [CrossRef]
  51. Huang, T.; Li, F.; Xia, Y.; Zhao, J.; Zhu, Y.; Liu, Y.; Qian, Y.; Zou, X. African swine fever virus immunosuppression and virulence-related gene. Curr. Issues Mol. Biol. 2024, 46, 8268–8281. [Google Scholar] [CrossRef]
  52. Zhu, Z.; Li, N.; Sun, Q.; Long, X.; Wang, T.; Qiu, H.-J. Host-similar fragments in the African swine fever virus genome: Distribution, functions, and evolution. Vet. Res. 2025, 56, 108. [Google Scholar] [CrossRef]
  53. Dixon, L.K.; Abrams, C.C.; Bowick, G.; Goatley, L.C.; Kay-Jackson, P.C.; Chapman, D.; Liverani, E.; Nix, R.; Silk, R.; Zhang, F. African swine fever virus proteins involved in evading host defence systems. Vet. Immunol. Immunopathol. 2004, 100, 117–134. [Google Scholar] [CrossRef]
  54. Tamás, V.; Righi, C.; Mészáros, I.; D’Errico, F.; Olasz, F.; Casciari, C.; Zádori, Z.; Magyar, T.; Petrini, S.; Feliziani, F. Involvement of the MGF 110-11L gene in the African swine fever replication and virulence. Vaccines 2023, 11, 846. [Google Scholar] [CrossRef]
  55. Bao, J.; Zhang, Y.; Shi, C.; Wang, Q.; Wang, S.; Wu, X.; Cao, S.; Xu, F.; Wang, Z. Genome-wide diversity analysis of African swine fever virus based on a curated dataset. Animals 2022, 12, 2446. [Google Scholar] [CrossRef]
  56. Sanna, G.; Dei Giudici, S.; Bacciu, D.; Angioi, P.; Giammarioli, M.; De Mia, G.; Oggiano, A. Improved strategy for molecular characterization of African swine fever viruses from Sardinia, based on analysis of p30, CD2V and I73R/I329L variable regions. Transbound. Emerg. Dis. 2017, 64, 1280–1286. [Google Scholar] [CrossRef] [PubMed]
  57. Cho, K.-H.; Kim, D.-Y.; Hong, S.-K.; Yoo, D.-S.; Kang, H.-E.; Kim, Y.-H. Detection of the intergenic region III and multigene family 505 9R and 10R-V variant of African swine fever virus genotype II on pig farms in South Korea. Arch. Virol. 2025, 170, 232. [Google Scholar] [CrossRef] [PubMed]
  58. Joel, G.S.; Jambol, A.R.; Jahota, N.D.; Li, F.; Njuki, R.N.; Odongo, L.A.; Ruth, M.O.; Ayuba, G.G.; ThankGod, D.G.; Jagab, S.H. Genome sequencing reveals variation of African swine fever virus in Nigerian outbreaks and identification of two major West African viral lineages. Microb. Genom. 2026, 12, 001636. [Google Scholar] [CrossRef]
  59. Qu, H.; Ge, S.; Zhang, Y.; Wu, X.; Wang, Z. A systematic review of genotypes and serogroups of African swine fever virus. Virus Genes 2022, 58, 77–87. [Google Scholar] [CrossRef] [PubMed]
  60. Spinard, E.; Dinhobl, M.; Tesler, N.; Birtley, H.; Signore, A.V.; Ambagala, A.; Masembe, C.; Borca, M.V.; Gladue, D.P. A re-evaluation of African swine fever genotypes based on p72 sequences reveals the existence of only six distinct p72 groups. Viruses 2023, 15, 2246. [Google Scholar] [CrossRef]
  61. Xin, G.; Kuang, Q.; Le, S.; Wu, W.; Gao, Q.; Gao, H.; Xu, Z.; Zheng, Z.; Lu, G.; Gong, L. Origin, genomic diversity and evolution of African swine fever virus in East Asia. Virus Evol. 2023, 9, vead060. [Google Scholar] [CrossRef]
  62. Mazur-Panasiuk, N.; Woźniakowski, G. The unique genetic variation within the O174L gene of Polish strains of African swine fever virus facilitates tracking virus origin: N. Mazur-Panasiuk, G. Woźniakowski. Arch. Virol. 2019, 164, 1667–1672. [Google Scholar]
  63. Gallardo, C.; Casado, N.; Soler, A.; Djadjovski, I.; Krivko, L.; Madueño, E.; Nieto, R.; Perez, C.; Simon, A.; Ivanova, E. A multi gene-approach genotyping method identifies 24 genetic clusters within the genotype II-European African swine fever viruses circulating from 2007 to 2022. Front. Vet. Sci. 2023, 10, 1112850. [Google Scholar] [CrossRef]
  64. Giammarioli, M.; Torresi, C.; Biccheri, R.; Cammà, C.; Marcacci, M.; Dondo, A.; Razzuoli, E.; Fusco, G.; Casalinuovo, F.; Scicluna, M.T. Genetic characterization of african swine fever italian clusters in the 2022–2023 epidemic wave by a multi-gene approach. Viruses 2024, 16, 1185. [Google Scholar] [CrossRef]
  65. Forth, J.H.; Calvelage, S.; Fischer, M.; Hellert, J.; Sehl-Ewert, J.; Roszyk, H.; Deutschmann, P.; Reichold, A.; Lange, M.; Thulke, H.-H. African swine fever virus–variants on the rise. Emerg. Microbes Infect. 2023, 12, 2146537. [Google Scholar]
  66. Zhenzhong, W.; Chuanxiang, Q.; Shengqiang, G.; Jinming, L.; Yongxin, H.; Xiaoyue, Z.; Yan, L.; Naijun, H.; Xiaodong, W.; Zhiliang, W. Genetic variation and evolution of attenuated African swine fever virus strain isolated in the field. Virus Res. 2022, 319, 198874. [Google Scholar] [CrossRef] [PubMed]
  67. Weng, C. Current research progress on the viral immune evasion mechanisms of African swine fever virus. Anim. Dis. 2024, 4, 18. [Google Scholar] [CrossRef]
  68. Li, M.; Zheng, H. Insights and progress on epidemic characteristics, pathogenesis, and preventive measures of African swine fever virus: A review. Virulence 2025, 16, 2457949. [Google Scholar] [CrossRef] [PubMed]
  69. Arutkumaran, S.; Deb, R.; Chakravarti, S.; Das, P.J.; Sengar, G.S.; Pegu, S.R.; Singh, I.; Kumar, S.; Rajkhowa, S.; Kumar, P. Investigating the RelA Gene’s role in African Swine fever tolerance: A study of Indian pigs. Microb. Pathog. 2025, 206, 107744. [Google Scholar] [CrossRef]
  70. Solikhah, T.I.; Rostiani, F.; Nanra, A.F.P.; Dewi, A.D.P.P.; Nurbadri, P.H.; Agustin, Q.A.D.; Solikhah, G.P. African swine fever virus: Virology, pathogenesis, clinical impact, and global control strategies. Vet. World 2025, 18, 1599. [Google Scholar] [CrossRef]
  71. Hooper, G.L.; Netherton, C.L.; Wright, E. Cell entry mechanisms of African swine fever virus. Virology 2024, 600, 110277. [Google Scholar] [CrossRef]
  72. Zheng, X.; Nie, S.; Feng, W.-H. Regulation of antiviral immune response by African swine fever virus (ASFV). Virol. Sin. 2022, 37, 157–167. [Google Scholar] [CrossRef]
  73. Ranathunga, L.; Abesinghe, S.; Cha, J.-W.; Dodantenna, N.; Chathuranga, K.; Weerawardhana, A.; Haluwana, D.; Gamage, N.; Lee, J.-S. Inhibition of STING-mediated type I IFN signaling by African swine fever virus DP71L. Vet. Res. 2025, 56, 27. [Google Scholar] [CrossRef]
  74. Lin, X. Mechanisms of immune evasion by african swine fever virus: An integrated review. Mol. Pathog. 2024, 15, 209–218. [Google Scholar] [CrossRef]
  75. Chen, Y.; Guo, Y.; Song, Z.; Chang, H.; Kuang, Q.; Zheng, Z.; Wang, H.; Zhang, G. Luteolin restricts ASFV replication by regulating the NF-κB/STAT3/ATF6 signaling pathway. Vet. Microbiol. 2022, 273, 109527. [Google Scholar] [CrossRef]
  76. Su, G.; Yang, X.; Lin, Q.; Su, G.; Liu, J.; Huang, L.; Chen, W.; Wei, W.; Chen, J. Fangchinoline inhibits African swine fever virus replication by suppressing the AKT/mTOR/NF-κB signaling pathway in porcine alveolar macrophages. Int. J. Mol. Sci. 2024, 25, 7178. [Google Scholar] [CrossRef]
  77. Wang, S.; Zhang, J.; Zhang, Y.; Yang, J.; Wang, L.; Qi, Y.; Han, X.; Zhou, X.; Miao, F.; Chen, T. Cytokine storm in domestic pigs induced by infection of virulent African swine fever virus. Front. Vet. Sci. 2020, 7, 601641. [Google Scholar] [CrossRef]
  78. Cochran, H.J.; Bosco-Lauth, A.M.; Garry, F.B.; Roman-Muniz, I.N.; Martin, J.N. African swine fever: A review of current disease management strategies and risks associated with exhibition swine in the United States. Animals 2023, 13, 3713. [Google Scholar] [CrossRef]
  79. Alotaibi, B.S.; Wu, C.-H.; Khan, M.; Nawaz, M.; Chen, C.-C.; Ali, A. African swine fever; insights into genomic aspects, reservoirs and transmission patterns of virus. Front. Vet. Sci. 2024, 11, 1413237. [Google Scholar] [CrossRef]
  80. Guinat, C.; Gogin, A.; Blome, S.; Keil, G.; Pollin, R.; Pfeiffer, D.U.; Dixon, L. Transmission routes of African swine fever virus to domestic pigs: Current knowledge and future research directions. Vet. Rec. 2016, 178, 262–267. [Google Scholar] [CrossRef]
  81. EFSA Panel on Animal Health and Welfare (EFSA AHAW Panel); Nielsen, S.S.; Alvarez, J.; Bicout, D.J.; Calistri, P.; Depner, K.; Drewe, J.A.; Garin-Bastuji, B.; Gonzales Rojas, J.L.; Gortázar Schmidt, C.; et al. Scientific Opinion on the assessment of the control measures of the category A diseases of Animal Health Law: African Swine Fever. EFSA J. 2021, 19, e06402. [Google Scholar] [CrossRef]
  82. Songkasupa, T.; Boonpornprasert, P.; Suwankitwat, N.; Lohlamoh, W.; Nuengjamnong, C.; Nuanualsuwan, S. Thermal inactivation of African swine fever virus in feed ingredients. Sci. Rep. 2022, 12, 15998. [Google Scholar] [CrossRef] [PubMed]
  83. Tu, Z.; Sun, H.; Wang, T.; Liu, Y.; Xu, Y.; Peng, P.; Qin, S.; Tu, C.; He, B. Node role of wild boars in virus circulation among wildlife and domestic animals. Nat. Commun. 2025, 16, 8938. [Google Scholar] [CrossRef] [PubMed]
  84. Brown, V.R.; Miller, R.S.; Pepin, K.M.; Carlisle, K.M.; Cook, M.A.; Vanicek, C.F.; Holmstrom, L.K.; Rochette, L.T.; Smyser, T.J. African swine fever at the wildlife-livestock interface: Challenges for management and outbreak response within invasive wild pigs in the United States. Front. Vet. Sci. 2024, 11, 1348123. [Google Scholar] [CrossRef] [PubMed]
  85. Authority, E.F.S.; Boklund, A.E.; Ståhl, K.; Miranda Chueca, M.Á.; Podgórski, T.; Vergne, T.; Cortiñas Abrahantes, J.; Cattaneo, E.; Dhollander, S.; Papanikolaou, A. Risk and protective factors for ASF in domestic pigs and wild boar in the EU, and mitigation measures for managing the disease in wild boar. EFSA J. 2024, 22, e9095. [Google Scholar] [CrossRef]
  86. Tummeleht, L.; Häkkä, S.S.S.; Jürison, M.; Vilem, A.; Nurmoja, I.; Viltrop, A. Wild boar (Sus scrofa) carcasses as an attraction for scavengers and a potential source for soil contamination with the African swine fever virus. Front. Vet. Sci. 2024, 11, 1305643. [Google Scholar] [CrossRef]
  87. Jori, F.; Bastos, A.; Boinas, F.; Van Heerden, J.; Heath, L.; Jourdan-Pineau, H.; Martinez-Lopez, B.; Pereira de Oliveira, R.; Pollet, T.; Quembo, C. An Updated Review of Ornithodoros Ticks as Reservoirs of African Swine Fever in Sub-Saharan Africa and Madagascar. Pathogens 2023, 12, 469. [Google Scholar] [CrossRef]
  88. Kayaga, E.B.; Wampande, E.M.; Ekakoro, J.E.; Okwasiimire, R.; Nassali, A.; Ochoa, K.; Hauser, C.; Ndoboli, D.; Havas, K.A. Detection of antibodies against Ornithodoros moubata salivary antigens and their association with detection of African swine fever virus in pigs slaughtered in central Uganda. Front. Vet. Sci. 2024, 11, 1328040. [Google Scholar] [CrossRef]
  89. Rock, D.L. Thoughts on African swine fever vaccines. Viruses 2021, 13, 943. [Google Scholar] [CrossRef]
  90. Sánchez-Vizcaíno, J.M.; Martínez-López, B.; Martínez-Avilés, M.; Martins, C.; Boinas, F.; Vialc, L.; Michaud, V.; Jori, F.; Etter, E.; Albina, E. Scientific review on African swine fever. EFSA Suppl. Publ. 2009, 6, 5E. [Google Scholar] [CrossRef]
  91. Gaudreault, N.N.; Madden, D.W.; Wilson, W.C.; Trujillo, J.D.; Richt, J.A. African swine fever virus: An emerging DNA arbovirus. Front. Vet. Sci. 2020, 7, 215. [Google Scholar] [CrossRef] [PubMed]
  92. Vergne, T.; Andraud, M.; Bonnet, S.; De Regge, N.; Desquesnes, M.; Fite, J.; Etore, F.; Garigliany, M.M.; Jori, F.; Lempereur, L. Mechanical transmission of African swine fever virus by Stomoxys calcitrans: Insights from a mechanistic model. Transbound. Emerg. Dis. 2021, 68, 1541–1549. [Google Scholar] [CrossRef] [PubMed]
  93. Montgomery, R.E. On a form of swine fever occurring in British East Africa (Kenya Colony). J. Comp. Pathol. Ther. 1921, 34, 159–191. [Google Scholar] [CrossRef]
  94. Mulumba-Mfumu, L.K.; Saegerman, C.; Dixon, L.K.; Madimba, K.C.; Kazadi, E.; Mukalakata, N.T.; Oura, C.A.; Chenais, E.; Masembe, C.; Ståhl, K. African swine fever: Update on Eastern, Central and Southern Africa. Transbound. Emerg. Dis. 2019, 66, 1462–1480. [Google Scholar] [CrossRef]
  95. Sukmanadi, M.; Khairullah, A.R.; Mustofa, I.; Wiyono, A.; Wardhani, B.W.K.; Saepulloh, M.; Proboningrat, A.; Wasito, W.; Putri, A.K.; Ahmad, R.Z. African swine fever: A highly fatal disease that is spreading globally. Open Vet. J. 2025, 15, 3399. [Google Scholar] [CrossRef]
  96. Wilkinson, N. The pathogenicity of two groups of African swine fever virus isolates from Cameroon in domestic pigs. Pathol. Infect. 1999, 52, 202–208. [Google Scholar]
  97. Penrith, M.-L. History of ‘swine fever’ in Southern Africa: Historical article. J. S. Afr. Vet. Assoc. 2013, 84, 1–6. [Google Scholar] [CrossRef]
  98. Sánchez-Vizcaíno, J.; Mur, L.; Martínez-López, B. African swine fever: An epidemiological update. Transbound. Emerg. Dis. 2012, 59, 27–35. [Google Scholar] [CrossRef]
  99. Plowright, W.; Thomson, G.; Neser, J.; Coetzer, J.; Tustin, R. Infectious Diseases of Livestock with Special Reference to Southern Africa; Oxford University Press Southern Africa: Cape Town, South Africa, 1994; Volume 112, pp. 567–599. [Google Scholar]
  100. Gallardo, M.C.; Reoyo, A.d.l.T.; Fernández-Pinero, J.; Iglesias, I.; Muñoz, M.J.; Arias, M.L. African swine fever: A global view of the current challenge. Porc. Health Manag. 2015, 1, 21. [Google Scholar] [CrossRef]
  101. Bosch, J.; Rodríguez, A.; Iglesias, I.; Muñoz, M.; Jurado, C.; Sánchez-Vizcaíno, J.; De la Torre, A. Update on the risk of introduction of African swine fever by wild boar into disease-free European Union countries. Transbound. Emerg. Dis. 2017, 64, 1424–1432. [Google Scholar] [PubMed]
  102. Danzetta, M.L.; Marenzoni, M.L.; Iannetti, S.; Tizzani, P.; Calistri, P.; Feliziani, F. African swine fever: Lessons to learn from past eradication experiences. A systematic review. Front. Vet. Sci. 2020, 7, 296. [Google Scholar] [CrossRef]
  103. Cwynar, P.; Stojkov, J.; Wlazlak, K. African swine fever status in Europe. Viruses 2019, 11, 310. [Google Scholar] [CrossRef]
  104. Korennoy, F.; Gulenkin, V.; Gogin, A.; Vergne, T.; Karaulov, A. Estimating the basic reproductive number for African swine fever using the Ukrainian historical epidemic of 1977. Transbound. Emerg. Dis. 2017, 64, 1858–1866. [Google Scholar] [CrossRef] [PubMed]
  105. Costard, S.; Mur, L.; Lubroth, J.; Sanchez-Vizcaino, J.M.; Pfeiffer, D.U. Epidemiology of African swine fever virus. Virus Res. 2013, 173, 191–197. [Google Scholar] [CrossRef]
  106. Laddomada, A.; Rolesu, S.; Loi, F.; Cappai, S.; Oggiano, A.; Madrau, M.P.; Sanna, M.L.; Pilo, G.; Bandino, E.; Brundu, D. Surveillance and control of African Swine Fever in free-ranging pigs in Sardinia. Transbound. Emerg. Dis. 2019, 66, 1114–1119. [Google Scholar] [CrossRef] [PubMed]
  107. Franzoni, G.; Dei Giudici, S.; Loi, F.; Sanna, D.; Floris, M.; Fiori, M.; Sanna, M.L.; Madrau, P.; Scarpa, F.; Zinellu, S. African swine fever circulation among free-ranging pigs in Sardinia: Data from the eradication program. Vaccines 2020, 8, 549. [Google Scholar] [CrossRef]
  108. Hayes, B.; Lim, J.; Andraud, M.; Vergne, T. Elucidating the influence of wild boar density on African swine fever spread in wild boar populations, Italy, 2022–2023. EFSA Suppl. Publ. 2024, 21, 9049E. [Google Scholar] [CrossRef]
  109. Schulz, K.; Calvelage, S.; Rogoll, L.; Conraths, F.J.; Staubach, C.; Albrecht, K.; Marquart, R.; Kühn, J.; Rudovsky, A.; Brunklaus, D. African swine fever outbreaks in German pig holdings–experiences, epidemiological considerations and genome sequences. Sci. Rep. 2026, 16, 4350. [Google Scholar] [CrossRef]
  110. Gámbaro, F.; Goatley, L.C.; Foster, T.J.; Tennakoon, C.; Freimanis, G.L.; Van Borm, S.; Masiulis, M.; Bušauskas, P.; Netherton, C.L.; Dellicour, S. Exploiting viral DNA genomes to explore the dispersal history of African swine fever genotype II lineages in Europe. Genome Biol. Evol. 2025, 17, evaf102. [Google Scholar] [CrossRef]
  111. Chenais, E.; Depner, K.; Guberti, V.; Dietze, K.; Viltrop, A.; Ståhl, K. Epidemiological considerations on African swine fever in Europe 2014–2018. Porc. Health Manag. 2019, 5, 6. [Google Scholar] [CrossRef]
  112. Rossi, G.; Leitch, E.C.M.; Graham, J.; Biccheri, R.; Iscaro, C.; Torresi, C.; Lycett, S.J.; Feliziani, F.; Giammarioli, M. A phylogenetic contribution to understanding the panzootic spread of African swine fever: From the global to the local scale. Virus Evol. 2026, 12, veaf103. [Google Scholar] [CrossRef] [PubMed]
  113. Ito, S.; Bosch, J.; Martínez-Avilés, M.; Sánchez-Vizcaíno, J.M. The evolution of African swine fever in China: A global threat? Front. Vet. Sci. 2022, 9, 828498. [Google Scholar] [CrossRef]
  114. Liu, J.; Liu, B.; Shan, B.; Wei, S.; An, T.; Shen, G.; Chen, Z. Prevalence of African swine fever in China, 2018–2019. J. Med. Virol. 2020, 92, 1023–1034. [Google Scholar] [CrossRef] [PubMed]
  115. Woonwong, Y.; Do Tien, D.; Thanawongnuwech, R. The future of the pig industry after the introduction of African swine fever into Asia. Anim. Front. 2020, 10, 30–37. [Google Scholar] [CrossRef]
  116. Chuong, V.D.; Schambow, R.A.; Diep, N.T.; Minh, P.Q.; Long, N.V.; To Nga, B.T.; Perez, A.M. Epidemiology and control of African swine fever in Vietnam: A scoping review. Pathogens 2025, 14, 329. [Google Scholar] [CrossRef]
  117. Pandarangga, P.; Gelolodo, M.; Toha, L.; Tearle, R.; Hemmatzadeh, F. Whole-genome sequence of African swine fever virus isolated in West Timor, Indonesia. Microbiol. Resour. Announc. 2025, 14, e00205–e00225. [Google Scholar] [CrossRef] [PubMed]
  118. Ito, S.; Kawaguchi, N.; Bosch, J.; Aguilar-Vega, C.; Sánchez-Vizcaíno, J.M. What can we learn from the five-year African swine fever epidemic in Asia? Front. Vet. Sci. 2023, 10, 1273417. [Google Scholar]
  119. Thakur, S.; Rana, C.; Joshi, N.P.; Neupane, L.; Pokhrel, T.R.; Shrestha, A.; Subedi, D. First Outbreak of African Swine Fever in Wild Boar in Nepal. Vet. Med. Sci. 2024, 10, e70067. [Google Scholar] [CrossRef]
  120. Ambagala, A.; Puvanendiran, S.; Jayathilake, B.; Goonewardene, K.; Hochman, O.; Benaragama, I.; Onyilagha, C.; Brawerman, G.; Maydaniuk, D.; Embury-Hyatt, C. Emergence of African Swine Fever in Sri Lanka, 2024. Viruses 2026, 18, 157. [Google Scholar] [CrossRef]
  121. Hakizimana, J.N.; Yona, C.; Kamana, O.; Nauwynck, H.; Misinzo, G. African swine fever virus circulation between Tanzania and neighboring countries: A systematic review and meta-analysis. Viruses 2021, 13, 306. [Google Scholar] [CrossRef]
  122. Schambow, R.A.; Carrasquillo, N.; Kreindel, S.; Perez, A.M. An update on active and passive surveillance for African swine fever in the Dominican Republic. Sci. Rep. 2025, 15, 2244. [Google Scholar] [CrossRef]
  123. de Menezes, T.C.; Countryman, A.M.; Pendell, D.L.; Rushton, J.; Tickel, J.; Simmons, H. Potential economy-wide impacts of an African swine fever outbreak in the United States. Front. Vet. Sci. 2026, 13, 1752899. [Google Scholar]
  124. Smith, D.; Cooper, T.; Pereira, A.; da Costa Jong, J.B. Counting the cost: The potential impact of African swine fever on smallholders in Timor-Leste. One Health 2019, 8, 100109. [Google Scholar] [CrossRef] [PubMed]
  125. Tenaya, W.M.; Swacita, I.B.N.; Wirata, K.; Damriyasa, M.; Besung, N.K.; Suarsana, N.; Sari, T.K.; Agustina, K.K. A study of African swine fever virus in Regional VI of the Disease Investigation Center of Denpasar Bali in Indonesia. Vet. World 2023, 16, 844. [Google Scholar] [CrossRef]
  126. Slatyer, R.; Hafi, A.; Richards, K.; Cozens, M.; Addai, D.; Cao, L.; Mornement, C.; Keighley, M.; Arthur, T. Potential Economic Consequences of African Swine Fever in Australia; Australian Bureau of Agricultural and Resource Economics and Sciences: Canberra, Australia, 2023.
  127. Liu, H.; Ren, Y.; Chu, H.; Shan, H.; Wong, K.W. A fuzzy risk assessment model used for assessing the introduction of African swine fever into Australia from overseas. Artif. Intell. Agric. 2023, 7, 27–34. [Google Scholar] [CrossRef]
  128. Bradhurst, R.; Garner, G.; Roche, S.; Iglesias, R.; Kung, N.; Robinson, B.; Willis, S.; Cozens, M.; Richards, K.; Cowled, B. Modelling the Spread and Control of African Swine Fever in Domestic and Feral Pigs; Australian Government, Department of Agriculture, Water and the Environment: Canberra, Australia, 2021.
  129. Shaw, C.; McLure, A.; Glass, K. Modelling African swine fever introduction in diverse Australian feral pig populations. Prev. Vet. Med. 2024, 228, 106212. [Google Scholar] [CrossRef]
  130. Liu, H.; Li, S.; Ren, Y.; Wong, K.W. Modelling the Influence of Temperature and Rainfall on the Spread of African Swine Fever in Australia. In Proceedings of the International Conference on Neural Information Processing, Auckland, New Zealand, 2–6 December 2024; pp. 102–117. [Google Scholar]
  131. Neumann, E.; Hall, W.; Dahl, J.; Hamilton, D.; Kurian, A. Is transportation a risk factor for African swine fever transmission in Australia: A review. Aust. Vet. J. 2021, 99, 459–468. [Google Scholar] [CrossRef]
  132. Coelho, I.M.P.; Paiva, M.T.; da Costa, A.J.A.; Nicolino, R.R. African Swine Fever: Spread and seasonal patterns worldwide. Prev. Vet. Med. 2025, 235, 106401. [Google Scholar] [CrossRef]
  133. APHA Report Highlights Widespread Presence of ASF in Europe. Available online: https://nationalpigassociation.co.uk/apha-report-highlights-widespread-presence-of-asf-in-europe/ (accessed on 4 March 2026).
  134. Dundon, W.G.; Franzo, G.; Settypalli, T.B.; Dharmayanti, N.I.; Ankhanbaatar, U.; Sendow, I.; Ratnawati, A.; Sainnokhoi, T.; Molini, U.; Cattoli, G. Evidence of coinfection of pigs with African swine fever virus and porcine circovirus 2. Arch. Virol. 2022, 167, 207–211. [Google Scholar] [CrossRef]
  135. Luka, P.D.; Adedeji, A.J.; Jambol, A.R.; Ifende, I.V.; Luka, H.G.; Choji, N.D.; Weka, R.; Settypalli, T.B.; Achenbach, J.E.; Cattoli, G. Coinfections of African swine fever virus, porcine circovirus 2 and 3, and porcine parvovirus 1 in swine in Nigeria. Arch. Virol. 2022, 167, 2715–2722. [Google Scholar] [CrossRef] [PubMed]
  136. Coronado, L.; Muñoz-Aguilera, A.; Wang, M.; Muñoz, I.; Riquelme, C.; Heredia, S.; Stępniewska, K.; Gallardo, C.; Ganges, L. Simultaneous detection of classical and African swine fever viruses by Duplex Taqman real-time PCR assay in pigs infected with both diseases. Pathogens 2025, 14, 473. [Google Scholar] [CrossRef] [PubMed]
  137. Venturina, V.M.; Gundran, R.S.; Rafael, R.B.; Salvador, R.T.; Salinas, M.B.S.; Balagan, E.J.Y.; Valdez, P.M.; Soriano, A.P.; Medina, N.P.; Garcia, G.G. Surveillance and Management Strategies for African Swine Fever (ASF) in Central Luzon, Philippines. Pathogens 2025, 14, 995. [Google Scholar] [CrossRef] [PubMed]
  138. Authority, E.F.S.; Ståhl, K.; Boklund, A.E.; Podgórski, T.; Vergne, T.; Abrahantes, J.C.; Cattaneo, E.; Papanikolaou, A.; Mur, L. Epidemiological analysis of African swine fever in the European Union during 2023. EFSA J. 2024, 22, e8809. [Google Scholar] [CrossRef]
  139. Dhollander, S.; Cattaneo, E.; Cortinas Abrahantes, J.; Boklund, A.; Szczotka-Bochniarz, A.; Mihalca, A.; Papanikolaou, A.; Mur, L.; Balmoș, O.; Frant, M. Prospective Case–Control Study of Determinants for African Swine Fever Introduction in Commercial Pig Farms in Poland, Romania, and Lithuania. Transbound. Emerg. Dis. 2025, 2025, 5419764. [Google Scholar] [CrossRef]
  140. Barnes, T.S.; Morais, O.; Cargill, C.; Parke, C.R.; Urlings, A. First steps in managing the challenge of African swine fever in Timor-Leste. One Health 2020, 10, 100151. [Google Scholar] [CrossRef]
  141. Mutua, F.; Dione, M. The context of application of biosecurity for control of African swine fever in smallholder pig systems: Current gaps and recommendations. Front. Vet. Sci. 2021, 8, 689811. [Google Scholar]
  142. Bisimwa, P.N.; Dione, M.; Basengere, B.; Mushagalusa, C.A.; Steinaa, L.; Ongus, J. Risk factors of African swine fever virus in suspected infected pigs in smallholder farming systems in South-Kivu province, Democratic Republic of Congo. J. Vet. Sci. 2021, 22, e35. [Google Scholar]
  143. Lichoti, J.K.; Davies, J.; Maru, Y.; Kitala, P.M.; Githigia, S.M.; Okoth, E.; Bukachi, S.A.; Okuthe, S.; Bishop, R.P. Pig traders’ networks on the Kenya-Uganda border highlight potential for mitigation of African swine fever virus transmission and improved ASF disease risk management. Prev. Vet. Med. 2017, 140, 87–96. [Google Scholar] [CrossRef]
  144. Kim, Y.-J.; Park, B.; Kang, H.-E. Control measures to African swine fever outbreak: Active response in South Korea, preparation for the future, and cooperation. J. Vet. Sci. 2021, 22, e13. [Google Scholar]
  145. African Swine Fever (ASF). Available online: https://www.fao.org/animal-health/animal-diseases/african-swine-fever/en (accessed on 25 May 2026).
  146. Arruda, A.G.; Beyene, T.J.; Kieffer, J.; Lorbach, J.N.; Moeller, S.; Bowman, A.S. A systematic literature review on depopulation methods for swine. Animals 2020, 10, 2161. [Google Scholar] [CrossRef] [PubMed]
  147. Nga, B.T.T.; Padungtod, P.; Depner, K.; Chuong, V.D.; Duy, D.T.; Anh, N.D.; Dietze, K. Implications of partial culling on African swine fever control effectiveness in Vietnam. Front. Vet. Sci. 2022, 9, 957918. [Google Scholar] [CrossRef]
  148. Nga, B.T.T.; Auer, A.; Padungtod, P.; Dietze, K.; Globig, A.; Rozstalnyy, A.; Hai, T.M.; Depner, K. Evaluation of selective culling as a containment strategy for African swine fever at a Vietnamese sow farm. Pathogens 2024, 13, 567. [Google Scholar] [CrossRef]
  149. Du, X.; Liu, Y.; Duan, L.; Tsai, S.-Y.; Yaros, J.P.; Wu, F. Elimination of ASFV via Precise Culling in a Large-Scale Breeding Herd in China: A Field Experience. Animals 2025, 15, 2521. [Google Scholar] [CrossRef]
  150. Gervasi, V.; Marcon, A.; Guberti, V. Estimating the risk of environmental contamination by forest users in African Swine Fever endemic areas. Acta Vet. Scand. 2022, 64, 16. [Google Scholar] [CrossRef]
  151. Cowled, B.D.; Garner, M.G.; Negus, K.; Ward, M.P. Controlling disease outbreaks in wildlife using limited culling: Modelling classical swine fever incursions in wild pigs in Australia. Vet. Res. 2012, 43, 3. [Google Scholar] [CrossRef] [PubMed]
  152. EADRA Compensation and Valuation. Available online: https://animalhealthaustralia.com.au/eadra/eadra-compensation-and-valuation/ (accessed on 25 May 2026).
  153. Emergency Animal Disease Bulletin No. 120: African Swine Fever. Available online: https://www.agriculture.gov.au/biosecurity-trade/pests-diseases-weeds/animal/ead-bulletin/ead-bulletin-no-120 (accessed on 12 August 2021).
  154. Costard, S.; Zagmutt, F.J.; Porphyre, T.; Pfeiffer, D.U. Small-scale pig farmers’ behavior, silent release of African swine fever virus and consequences for disease spread. Sci. Rep. 2015, 5, 17074. [Google Scholar] [CrossRef] [PubMed]
  155. Regional Strategy for the Control of African Swine Fever in Africa. Available online: https://rr-africa.woah.org/app/uploads/2025/07/ASF-Control-Strategy-AU-IBAR-2023.pdf (accessed on 21 July 2025).
  156. Thakur, S.; Shrestha, K.; Acharya, R.C.; Gurung, P.; Karki, S. African swine fever in Nepal: Risk factors, impacts and strategies for control. Sci. One Health 2026, 5, 100150. [Google Scholar] [CrossRef]
  157. Chen, W.; Zhao, D.; He, X.; Liu, R.; Wang, Z.; Zhang, X.; Li, F.; Shan, D.; Chen, H.; Zhang, J. A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs. Sci. China Life Sci. 2020, 63, 623–634. [Google Scholar] [CrossRef] [PubMed]
  158. Liu, J.; Ding, L.; Chen, W.; Zhao, D.; Liu, W.; Liu, Y.; Li, F.; Liu, R.; Huo, H.; Zhu, Y. Live-attenuated African swine fever vaccine HLJ/18-7GD is safe in pregnant sows with no impact on reproductive performance or offspring health at a field farm. Emerg. Microbes Infect. 2026, 15, 2614713. [Google Scholar] [CrossRef]
  159. Van den Born, E.; Olasz, F.; Mészáros, I.; Göltl, E.; Oláh, B.; Joshi, J.; van Kilsdonk, E.; Segers, R.; Zádori, Z. African swine fever virus vaccine strain Asfv-G-∆ I177l reverts to virulence and negatively affects reproductive performance. npj Vaccines 2025, 10, 46. [Google Scholar] [CrossRef]
  160. Nguyen, T.C.; Bui, N.T.T.; Nguyen, L.T.; Ngo, T.N.T.; Van Nguyen, C.; Nguyen, L.M.; Nouhin, J.; Karlsson, E.; Padungtod, P.; Pamornchainavakul, N. An African swine fever vaccine-like variant with multiple gene deletions caused reproductive failure in a Vietnamese breeding herd. Sci. Rep. 2025, 15, 14919. [Google Scholar] [CrossRef]
  161. Liu, W.; Li, H.; Liu, B.; Lv, T.; Yang, C.; Chen, S.; Feng, L.; Lai, L.; Duan, Z.; Chen, X. A new vaccination regimen using adenovirus-vectored vaccine confers effective protection against African swine fever virus in swine. Emerg. Microbes Infect. 2023, 12, 2233643. [Google Scholar] [CrossRef]
  162. Goatley, L.C.; Reis, A.L.; Portugal, R.; Goldswain, H.; Shimmon, G.L.; Hargreaves, Z.; Ho, C.-S.; Montoya, M.; Sánchez-Cordón, P.J.; Taylor, G. A pool of eight virally vectored African swine fever antigens protect pigs against fatal disease. Vaccines 2020, 8, 234. [Google Scholar] [CrossRef]
  163. Tng, P.Y.; Al-Adwani, L.; Goatley, L.C.; Loundras, E.-A.; Powers, C.; Netherton, C.L. African swine fever virus genes vectored by simian adenoviruses do not protect against virulent genotype II virus challenge. Microbiol. Spectr. 2026, 14, e02328-25. [Google Scholar] [CrossRef] [PubMed]
  164. Kumar, R.; Kim, T.; Zajac, M.D.; Libanori-Artiaga, B.; Sang, H.; Sangewar, N.; Heitmann, E.; Deepak, K.; McCall, J.; Burton, L. Live-vectored antigen cocktail confers protection against African swine fever virus (ASFV) Georgia 2007/1 challenge. npj Vaccines 2026, 11, 66. [Google Scholar] [CrossRef] [PubMed]
  165. Venkateswaran, D.; Prakash, A.; Nguyen, Q.A.; Suntisukwattana, R.; Atthaapa, W.; Tantituvanont, A.; Nilubol, D. Designing a multi-epitope vaccine against African swine fever virus using immunoinformatics approach. Sci. Rep. 2025, 15, 16044. [Google Scholar] [CrossRef]
  166. Abkallo, H.M.; Svitek, N.; Oduor, B.; Awino, E.; Henson, S.P.; Oyola, S.O.; Mwalimu, S.; Assad-Garcia, N.; Fuchs, W.; Vashee, S. Rapid CRISPR/Cas9 editing of genotype IX African swine fever virus circulating in eastern and central Africa. Front. Genet. 2021, 12, 733674. [Google Scholar] [CrossRef]
  167. Gladue, D.P. CRISPR-Cas9, a tool to efficiently increase the development of recombinant African swine fever viruses OPEN. Sci. Rep. 2018, 8, 3154. [Google Scholar]
  168. Yang, Y.; Yuan, H.; Zhang, Y.; Luan, J.; Wang, H. Progress in African swine fever vector vaccine development. Int. J. Mol. Sci. 2025, 26, 921. [Google Scholar] [CrossRef]
  169. Gaudreault, N.N.; Richt, J.A. Subunit vaccine approaches for African swine fever virus. Vaccines 2019, 7, 56. [Google Scholar] [CrossRef] [PubMed]
  170. Zhang, H.; Zhao, S.; Zhang, H.; Qin, Z.; Shan, H.; Cai, X. Vaccines for African swine fever: An update. Front. Microbiol. 2023, 14, 1139494. [Google Scholar] [CrossRef]
  171. Ntakiyisumba, E.; Tanveer, M.; Hirwa, F.; Won, G. Quantitative evaluation of the efficacy of non-replicating vaccines for controlling African swine fever in domestic pigs: A systematic review and meta-analysis. Front. Vet. Sci. 2025, 12, 1614479. [Google Scholar] [CrossRef]
  172. Vu, H.L.; McVey, D.S. Recent progress on gene-deleted live-attenuated African swine fever virus vaccines. npj Vaccines 2024, 9, 60. [Google Scholar] [CrossRef]
  173. Beckmann, J.; Blome, S.; Bujan, N.; Gortázar, C.; Holzum, T.; Ortmann, S.; Relimpio, D.; Schäfer, A.; Viaplana, E.; Vos, A. Oral Bait Immunization of Eurasian Wild Boar (Sus scrofa) Against African Swine Fever with “ASFV-G-ΔI177L”: Bait Performance, Immunogenicity, and Environmental Monitoring. Vaccines 2026, 14, 193. [Google Scholar] [CrossRef]
  174. Kosowska, A.; Sánchez-Segovia, M.; Fernández-Pinero, J.; Porras, N.; Barroso-Arévalo, S.; Sánchez-Morales, L.; Díaz-Frutos, M.; Barasona, J.A. Ineffective oral immunization of wild boar with the attenuated African swine fever virus NH/P68 grown in MA104 cell line. Vet. J. 2026, 315, 106554. [Google Scholar] [CrossRef]
  175. Auer, A.; Cattoli, G.; Padungtod, P.; Lamien, C.E.; Oh, Y.; Jayme, S.; Rozstalnyy, A. Challenges in the application of African swine fever vaccines in Asia. Animals 2024, 14, 2473. [Google Scholar] [CrossRef]
  176. Chandana, M.; Nair, S.S.; Chaturvedi, V.; Abhishek; Pal, S.; Charan, M.S.S.; Balaji, S.; Saini, S.; Vasavi, K.; Deepa, P. Recent progress and major gaps in the vaccine development for African swine fever. Braz. J. Microbiol. 2024, 55, 997–1010. [Google Scholar] [CrossRef]
  177. African swine fever: WOAH Vaccine Standard Adopted. Available online: https://www.woah.org/en/article/african-swine-fever-woah-vaccine-standard-adopted/ (accessed on 29 May 2025).
  178. Klein, L.; Gerdes, U.; Blome, S.; Campe, A.; Große Beilage, E. Biosecurity measures for the prevention of African swine fever on German pig farms: Comparison of farmers’ own appraisals and external veterinary experts’ evaluations. Porc. Health Manag. 2024, 10, 14. [Google Scholar] [CrossRef]
  179. Wang, J.; Shi, Z.; Hu, X. Status, evaluation, and influencing factors of biosecurity levels in pig farms in China. BMC Vet. Res. 2023, 19, 272. [Google Scholar] [CrossRef]
  180. Fleming, C.; Mills, K.; Cardenas, N.C.; Galvis, J.A.; Corzo, C.; Machado, G. Enhancing US swine farm preparedness for infectious foreign animal diseases with rapid access to biosecurity information. Prev. Vet. Med. 2025, 248, 106765. [Google Scholar] [CrossRef]
  181. Pig Biosecurity Management Plan: Information Guide. Available online: https://www.farmbiosecurity.com.au/wp-content/uploads/2021/08/Pig-BMP_Information-guide.pdf (accessed on 25 May 2026).
  182. Scollo, A.; Valentini, F.; Franceschini, G.; Rusinà, A.; Calò, S.; Cappa, V.; Bellato, A.; Mannelli, A.; Alborali, G.L.; Bellini, S. Semi-quantitative risk assessment of African swine fever virus introduction in pig farms. Front. Vet. Sci. 2023, 10, 1017001. [Google Scholar] [CrossRef]
  183. Laanen, M.; Persoons, D.; Ribbens, S.; de Jong, E.; Callens, B.; Strubbe, M.; Maes, D.; Dewulf, J. Relationship between biosecurity and production/antimicrobial treatment characteristics in pig herds. Vet. J. 2013, 198, 508–512. [Google Scholar] [CrossRef]
  184. Postma, M.; Backhans, A.; Collineau, L.; Loesken, S.; Sjölund, M.; Belloc, C.; Emanuelson, U.; Grosse Beilage, E.; Nielsen, E.O.; Stärk, K.D. Evaluation of the relationship between the biosecurity status, production parameters, herd characteristics and antimicrobial usage in farrow-to-finish pig production in four EU countries. Porc. Health Manag. 2016, 2, 9. [Google Scholar] [CrossRef]
  185. Brown, V.R.; Miller, R.S.; McKee, S.C.; Ernst, K.H.; Didero, N.M.; Maison, R.M.; Grady, M.J.; Shwiff, S.A. Risks of introduction and economic consequences associated with African swine fever, classical swine fever and foot-and-mouth disease: A review of the literature. Transbound. Emerg. Dis. 2021, 68, 1910–1965. [Google Scholar] [CrossRef]
  186. Taylor, R.A.; Condoleo, R.; Simons, R.R.; Gale, P.; Kelly, L.A.; Snary, E.L. The risk of infection by African swine fever virus in European swine through boar movement and legal trade of pigs and pig meat. Front. Vet. Sci. 2020, 6, 486. [Google Scholar] [CrossRef]
  187. Pavone, S.; Biccheri, R.; Beato, M.S.; Iscaro, C.; Montagnin, C.; Casciari, C.; Costantino, G.; Righi, C.; Torresi, C.; Petrini, S. Targeted Monitoring on Illegal Suid Meat and Meat Products Trade in Italy: African Swine Fever Detection and Implications for Transboundary Spread. Transbound. Emerg. Dis. 2025, 2025, 4119953. [Google Scholar] [CrossRef]
  188. Kim, H.-J.; Lee, M.-J.; Lee, S.-K.; Kim, D.-y.; Seo, S.-J.; Kang, H.-E.; Nam, H.-M. African swine fever virus in pork brought into South Korea by travelers from China, August 2018. Emerg. Infect. Dis. 2019, 25, 1231. [Google Scholar] [CrossRef]
  189. Arcega Castillo, G.; Schultze, M.L.; Schulte, R.; Schambow, R.A.; Hervé-Claude, L.P.; León, E.A.; Perez, A.M. African swine fever incursion risks in Latin America and the Caribbean: Informal and legal import pathways. Front. Vet. Sci. 2025, 12, 1587131. [Google Scholar] [CrossRef]
  190. Ruiz-Saenz, J.; Diaz, A.; Bonilla-Aldana, D.K.; Rodríguez-Morales, A.J.; Martinez-Gutierrez, M.; Aguilar, P.V. African swine fever virus: A re-emerging threat to the swine industry and food security in the Americas. Front. Microbiol. 2022, 13, 1011891. [Google Scholar] [CrossRef]
  191. Australia’s Biosecurity and Border Controls. Available online: https://www.smartraveller.gov.au/while-youre-away/biosecurity-border (accessed on 23 January 2026).
  192. Compliance and Enforcement. Available online: https://www.agriculture.gov.au/biosecurity-trade/policy/legislation/compliance (accessed on 25 October 2022).
  193. Chenais, E.; Sternberg-Lewerin, S.; Aliro, T.; Ståhl, K.; Fischer, K. Co-created community contracts support biosecurity changes in a region where African swine fever is endemic–Part I: The methodology. Prev. Vet. Med. 2023, 212, 105840. [Google Scholar] [CrossRef]
  194. FAO Regional Office for Europe and Central Asia. Available online: https://www.fao.org/europe/en (accessed on 25 May 2026).
  195. Biosecurity Queensland—African Swine Fever Prevention and Preparedness Project. Available online: https://www.agriculture.gov.au/about/news/aba-biosecurity-qld (accessed on 25 November 2024).
  196. Dione, M.M.; Akol, J.; Roesel, K.; Kungu, J.; Ouma, E.A.; Wieland, B.; Pezo, D. Risk factors for African swine fever in smallholder pig production systems in Uganda. Transbound. Emerg. Dis. 2017, 64, 872–882. [Google Scholar] [CrossRef]
  197. The National Feral Pig Action Plan. Available online: https://feralpigs.com.au/ (accessed on 6 October 2021).
  198. Good Practices for Biosecurity in the Pig Sector—Issues and Options in Developing and Transition Countries. Available online: https://www.fao.org/4/i1435e/i1435e00.htm (accessed on 25 May 2026).
  199. Jean-Pierre, R.P.; Hagerman, A.D.; Rich, K.M. An analysis of African swine fever consequences on rural economies and smallholder swine producers in Haiti. Front. Vet. Sci. 2022, 9, 960344. [Google Scholar] [CrossRef]
  200. Aliro, T.; Chenais, E.; Odongo, W.; Okello, D.; Masembe, C.; Ståhl, K. Prevention and control of African swine fever in the smallholder pig value chain in Northern Uganda: Thematic analysis of stakeholders’ perceptions. Front. Vet. Sci. 2022, 8, 707819. [Google Scholar]
  201. Mishra, A.; Sharma, A.; Kaur, I.; Barman, N.N.; Buragohain, L.; Deka, A.; Malik, Y.S. African Swine Fever Virus: Insights into a Global Epidemic. In Global Virology V: 21st Century Vaccines and Viruses; Springer: Berlin/Heidelberg, Germany, 2025; pp. 1–28. [Google Scholar]
  202. Islam, M.A.; Rony, S.A.; Rahman, M.B.; Cinar, M.U.; Villena, J.; Uddin, M.J.; Kitazawa, H. Improvement of disease resistance in livestock: Application of immunogenomics and CRISPR/Cas9 technology. Animals 2020, 10, 2236. [Google Scholar] [CrossRef]
  203. Wu, C.; Wang, H.; Zhang, W.; Cheng, M.; Wang, Y.; Chen, L.; Tang, C.; Dai, Y.; Zhang, L. Pigs with CD163 Mutation Conferred PRRSV Resistance. Animals 2026, 16, 850. [Google Scholar] [CrossRef] [PubMed]
  204. Liu, Y.; Yang, L.; Xiang, H.-Y.; Niu, M.; Deng, J.-C.; Li, X.-Y.; Hao, W.-J.; Ou-Yang, H.-S.; Liu, T.-Y.; Tang, X.-C. Genetically modified pigs with CD163 point mutation are resistant to HP-PRRSV infection. Zool. Res. 2024, 45, 833. [Google Scholar] [CrossRef] [PubMed]
  205. Chen, J.; Wang, H.; Bai, J.; Liu, W.; Liu, X.; Yu, D.; Feng, T.; Sun, Z.; Zhang, L.; Ma, L. Generation of pigs resistant to highly pathogenic-porcine reproductive and respiratory syndrome virus through gene editing of CD163. Int. J. Biol. Sci. 2019, 15, 481. [Google Scholar] [CrossRef]
  206. Burkard, C.; Lillico, S.G.; Reid, E.; Jackson, B.; Mileham, A.J.; Ait-Ali, T.; Whitelaw, C.B.A.; Archibald, A.L. Precision engineering for PRRSV resistance in pigs: Macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function. PLoS Pathog. 2017, 13, e1006206. [Google Scholar] [CrossRef]
  207. Sánchez-Torres, C.; Gómez-Puertas, P.; Gomez-del-Moral, M.; Alonso, F.; Escribano, J.; Ezquerra, A.; Domínguez, J. Expression of porcine CD163 on monocytes/macrophages correlates with permissiveness to African swine fever infection. Arch. Virol. 2003, 148, 2307–2323. [Google Scholar] [CrossRef]
  208. Popescu, L.; Gaudreault, N.N.; Whitworth, K.M.; Murgia, M.V.; Nietfeld, J.C.; Mileham, A.; Samuel, M.; Wells, K.D.; Prather, R.S.; Rowland, R.R. Genetically edited pigs lacking CD163 show no resistance following infection with the African swine fever virus isolate, Georgia 2007/1. Virology 2017, 501, 102–106. [Google Scholar] [CrossRef] [PubMed]
  209. Pannhorst, K.; Carlson, J.; Hölper, J.E.; Grey, F.; Baillie, J.K.; Höper, D.; Wöhnke, E.; Franzke, K.; Karger, A.; Fuchs, W. The non-classical major histocompatibility complex II protein SLA-DM is crucial for African swine fever virus replication. Sci. Rep. 2023, 13, 10342. [Google Scholar] [CrossRef]
  210. Zheng, Z.; Xu, L.; Gao, Y.; Dou, H.; Zhou, Y.; Feng, X.; He, X.; Tian, Z.; Song, L.; Mo, G. Testing multiplexed anti-ASFV CRISPR-Cas9 in reducing African swine fever virus. Microbiol. Spectr. 2024, 12, e02164-23. [Google Scholar] [CrossRef]
  211. Shen, D.; Zhang, G.; Weng, X.; Liu, R.; Liu, Z.; Sheng, X.; Zhang, Y.; Liu, Y.; Mu, Y.; Zhu, Y. A genome-wide CRISPR/Cas9 knockout screen identifies TMEM239 as an important host factor in facilitating African swine fever virus entry into early endosomes. PLoS Pathog. 2024, 20, e1012256. [Google Scholar] [CrossRef]
  212. Arutkumaran, S.; Deb, R.; Shanmathi, S.; Das, P.J.; Sengar, G.S.; Pegu, S.R.; Singh, I.; Kumar, S.; Meera, K.; Rajkhowa, S. Exploring ASFV tolerance in Indian pigs: A genetic and relative expression study of the STING1 gene. Arch. Virol. 2026, 171, 146. [Google Scholar] [CrossRef] [PubMed]
  213. Qi, F.; Chen, X.; Wang, J.; Niu, X.; Li, S.; Huang, S.; Ran, X. Genome-wide characterization of structure variations in the Xiang pig for genetic resistance to African swine fever. Virulence 2024, 15, 2382762. [Google Scholar] [CrossRef]
  214. Feng, W.; Zhou, L.; Zhao, P.; Du, H.; Diao, C.; Zhang, Y.; Liu, Z.; Jin, W.; Yu, J.; Han, J. Comparative genomic analysis of warthog and Sus scrofa identifies adaptive genes associated with African swine fever. Biology 2023, 12, 1001. [Google Scholar] [CrossRef] [PubMed]
  215. Li, J.; Xing, H.; Liu, K.; Fan, N.; Xu, K.; Zhao, H.; Jiao, D.; Wei, T.; Cheng, W.; Guo, J. Dysfunction of Complementarity Determining Region 1 Encoded by T Cell Receptor Beta Variable Gene Is Potentially Associated with African Swine Fever Virus Infection in Pigs. Microorganisms 2024, 12, 1113. [Google Scholar] [CrossRef]
  216. Tu, C.-F.; Chuang, C.-k.; Yang, T.-S. The application of new breeding technology based on gene editing in pig industry—A review. Anim. Biosci. 2022, 35, 791. [Google Scholar] [CrossRef]
  217. Penrith, M.-L.; Van Emmenes, J.; Hakizimana, J.N.; Heath, L.; Kabuuka, T.; Misinzo, G.; Odoom, T.; Wade, A.; Zerbo, H.L.; Luka, P.D. African swine fever diagnosis in Africa: Challenges and opportunities. Pathogens 2024, 13, 296. [Google Scholar] [CrossRef]
  218. Reviriego-Gordejo, F.; Minne, D.; Claassen, I.; Cavitte, J.-C.; Bouma, A.; Debaere, O.; Bastian, M.; Sammin, D.; Bénéré, E.; Bergevoet, R. Preparedness and response to emerging veterinary disease outbreaks–A. Biologicals 2026, 93, 3. [Google Scholar] [CrossRef] [PubMed]
  219. Global Control of African Swine Fever: A GF-TADs Initiative (2020–2025). Available online: https://www.woah.org/app/uploads/2021/06/global-control-of-african-swine-fever-a-gf-tads-initiative-2020-2025.pdf (accessed on 25 May 2026).
  220. El Hicheri, K.; Gomez-Tejedor, C.; Penrith, M.; Davies, G.; Douati, A.; Edoukou, G.; Wojciechowski, K. 1996 en Cote d’Ivoire. Rev. Sci. Tech. Off. Int. Epiz. 1998, 17, 660–673. [Google Scholar] [CrossRef]
  221. Brown, A.A.; Penrith, M.L.; Fasina, F.O.; Beltran-Alcrudo, D. The African swine fever epidemic in West Africa, 1996–2002. Transbound. Emerg. Dis. 2018, 65, 64–76. [Google Scholar] [CrossRef]
  222. Randriamparany, T.; Ravaomanana, F.; de Borgia, N. 2.4 Use of filter paper to rapidly diagnose African swine fever in Madagascar. In Case Studies of the Use of Agricultural Biotechnologies to Meet the Needs of Smallholders in Developing Countries; FAO: Rome, Italy, 2023; p. 31. [Google Scholar]
  223. Ravaomanana, J.; Jori, F.; Vial, L.; Pérez-Sánchez, R.; Blanco, E.; Michaud, V.; Roger, F. Assessment of interactions between African swine fever virus, bushpigs (Potamochoerus larvatus), Ornithodoros ticks and domestic pigs in north-western Madagascar. Transbound. Emerg. Dis. 2011, 58, 247–254. [Google Scholar] [CrossRef] [PubMed]
  224. Gonzague, M.; Roger, F.; Bastos, A.; Burger, C.; Randriamparany, T.; Smondack, S.; Crucière, C. Isolation of a non-haemadsorbing, non-cytopathic strain of African swine fever virus in Madagascar. Epidemiol. Infect. 2001, 126, 453–459. [Google Scholar] [CrossRef][Green Version]
  225. Kouakou, K.V.; Michaud, V.; Biego, H.G.; Gnabro, H.; Kouakou, A.; Mossoun, A.; Awuni, J.A.; Minoungou, G.L.; Aplogan, G.; Awoumé, F. African and classical swine fever situation in Ivory-Coast and neighboring countries, 2008–2013. Acta Trop. 2017, 166, 241–248. [Google Scholar] [CrossRef] [PubMed]
  226. Minoungou, G.L.; Diop, M.; Dakouo, M.; Ouattara, A.K.; Settypalli, T.B.K.; Lo, M.M.; Sidibe, S.; Kanyala, E.; Kone, Y.S.; Diallo, M.S. Molecular characterization of African swine fever viruses in Burkina Faso, Mali, and Senegal 1989–2016: Genetic diversity of ASFV in West Africa. Transbound. Emerg. Dis. 2021, 68, 2842–2852. [Google Scholar] [CrossRef]
  227. Boinas, F.S.; Wilson, A.J.; Hutchings, G.H.; Martins, C.; Dixon, L.J. The persistence of African swine fever virus in field-infected Ornithodoros erraticus during the ASF endemic period in Portugal. PLoS ONE 2011, 6, e20383. [Google Scholar] [CrossRef]
  228. Gogin, A.; Gerasimov, V.; Malogolovkin, A.; Kolbasov, D. African swine fever in the North Caucasus region and the Russian Federation in years 2007–2012. Virus Res. 2013, 173, 198–203. [Google Scholar] [CrossRef]
  229. Authority, E.F.S.; Abrahantes, J.C.; Gogin, A.; Richardson, J.; Gervelmeyer, A. Epidemiological analyses on African swine fever in the Baltic countries and Poland. EFSA J. 2017, 15, e04732. [Google Scholar] [CrossRef]
  230. Mačiulskis, P.; Masiulis, M.; Pridotkas, G.; Buitkuvienė, J.; Jurgelevičius, V.; Jacevičienė, I.; Zagrabskaitė, R.; Zani, L.; Pilevičienė, S. The African swine fever epidemic in wild boar (Sus scrofa) in Lithuania (2014–2018). Vet. Sci. 2020, 7, 15. [Google Scholar] [CrossRef]
  231. Wang, T.; Sun, Y.; Qiu, H.-J. African swine fever: An unprecedented disaster and challenge to China. Infect. Dis. Poverty 2018, 7, 66–70. [Google Scholar] [CrossRef] [PubMed]
  232. Mighell, E.; Ward, M.P. African swine fever spread across Asia, 2018–2019. Transbound. Emerg. Dis. 2021, 68, 2722–2732. [Google Scholar] [CrossRef]
  233. Subedi, D.; Subedi, S.; Karki, S. First outbreak of African swine fever in Nepal. Transbound. Emerg. Dis. 2022, 69, e3334–e3335. [Google Scholar] [CrossRef]
  234. ASF Situation in Asia & the Pacific. Available online: https://www.fao.org/animal-health/situation-updates/asf-in-asia-pacific/en (accessed on 19 March 2026).
  235. African Swine Fever in Europe—Updated Outbreak Assessment #39. Available online: https://assets.publishing.service.gov.uk/media/69a579f3bc86a487b52c7161/African_swine_fever_in_Europe_-_updated_outbreak_assessment_24_Feb_2026.pdf (accessed on 24 February 2026).
  236. African Swine Fever (ASF) Situation Report 74: Period Covered: February 2026. Available online: https://www.woah.org/app/uploads/2026/03/asf-report-74.pdf (accessed on 25 May 2026).
  237. Animal Health—March Update. Available online: https://www.face.eu/2026/04/animal-health-march-updates/ (accessed on 2 April 2026).
  238. Tran, X.H.; Phuong, L.T.T.; Huy, N.Q.; Thuy, D.T.; Nguyen, V.D.; Quang, P.H.; Ngôn, Q.V.; Rai, A.; Gay, C.G.; Gladue, D.P. Evaluation of the safety profile of the ASFV vaccine candidate ASFV-G-ΔI177L. Viruses 2022, 14, 896. [Google Scholar] [CrossRef]
  239. Borca, M.V.; Ramirez-Medina, E.; Mutisya, C.; Ojuok, R.; Odaba, J.; Dihbol, M.; Lacasta, A.; Gladue, D.P. Evaluation of cross-protection of African swine fever vaccine ASFV-G-ΔI177L between ASFV biotypes. Vaccines 2025, 13, 858. [Google Scholar]
  240. Monteagudo, P.L.; Lacasta, A.; López, E.; Bosch, L.; Collado, J.; Pina-Pedrero, S.; Correa-Fiz, F.; Accensi, F.; Navas, M.J.; Vidal, E. BA71ΔCD2: A new recombinant live attenuated African swine fever virus with cross-protective capabilities. J. Virol. 2017, 91. [Google Scholar] [CrossRef]
  241. Chu, X.; Ge, S.; Zuo, Y.; Cui, J.; Sha, Z.; Han, N.; Wu, B.; Ni, B.; Zhang, H.; Lv, Y. Thoughts on the research of African swine fever live-attenuated vaccines. Vaccine 2024, 42, 126052. [Google Scholar] [CrossRef]
  242. Gladue, D.P.; Borca, M.V. Recombinant ASF live attenuated virus strains as experimental vaccine candidates. Viruses 2022, 14, 878. [Google Scholar] [CrossRef]
  243. Zhang, Y.; Ke, J.; Zhang, J.; Yang, J.; Yue, H.; Zhou, X.; Qi, Y.; Zhu, R.; Miao, F.; Li, Q. African swine fever virus bearing an I226R gene deletion elicits robust immunity in pigs to African swine fever. J. Virol. 2021, 95, e0119921. [Google Scholar] [CrossRef] [PubMed]
  244. Yang, J.; Zhu, R.; Li, N.; Zhang, Y.; Zhou, X.; Yue, H.; Li, Q.; Wang, Y.; Miao, F.; Chen, T. Protection evaluation of a new attenuated ASFV by deletion of the L60L and CD2v genes against homologous challenge. Viruses 2024, 16, 1464. [Google Scholar] [PubMed]
  245. Jia, X.; Li, N.; Sun, X.; Ke, J.; Zheng, M.; Wang, F.; Yue, H.; Hao, Z.; Jiang, Y.; Li, Q. Hybrid genotype I and II ASFV D250R deletions confer protection against parental and genotype II strains and elicit potent immune response. Emerg. Microbes Infect. 2026, 15, 2640697. [Google Scholar] [CrossRef] [PubMed]
  246. Masa Tenaya, I.W.; Agustina, K.K.; Suada, I.K.; Pasti Apsari, I.A.; Sari, T.K.; Handayani, N.M.; Ayu Sauca Sunia Widayantari, A.A.; Komang Suardana, A.A.; Sumarya, I.; Arsana, I.N. Adaptation of African Swine Virus in Non-Swine Cell Lines: A Preliminary Study for Vaccine Candidate. J. Med. Vet. 2025, 8, 114–123. [Google Scholar] [CrossRef]
  247. Tenaya, I.; Agustina, K.K.; Suada, K.; Sukada, M.; Mufa, R.M.D.; Apsari, I.A.P.; Dwinata, I.M.; Ardana, I.B.K.; Damriyasa, M.; Sari, T.K.; et al. Pathogenesis studies of African swine fever virus isolates from Bali and East Nusa Tenggara as a basis for inactivated vaccine development. J. Med. Vet. 2026, 9, 150–160. [Google Scholar] [CrossRef]
  248. Cadenas-Fernández, E.; Sánchez-Vizcaíno, J.M.; Van den Born, E.; Kosowska, A.; van Kilsdonk, E.; Fernández-Pacheco, P.; Gallardo, C.; Arias, M.; Barasona, J.A. High doses of inactivated African swine fever virus are safe, but do not confer protection against a virulent challenge. Vaccines 2021, 9, 242. [Google Scholar] [CrossRef] [PubMed]
  249. Pikalo, J.; Porfiri, L.; Akimkin, V.; Roszyk, H.; Pannhorst, K.; Kangethe, R.T.; Wijewardana, V.; Sehl-Ewert, J.; Beer, M.; Cattoli, G. Vaccination with a gamma irradiation-inactivated African swine fever virus is safe but does not protect against a challenge. Front. Immunol. 2022, 13, 832264. [Google Scholar] [CrossRef]
  250. Neilan, J.G.; Zsak, L.; Lu, Z.; Burrage, T.G.; Kutish, G.F.; Rock, D.L. Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection. Virology 2004, 319, 337–342. [Google Scholar] [CrossRef]
  251. Wang, L.; Shi, J. African Swine Fever: Vaccine Advancement and Major Gaps. Microorganisms 2026, 14, 706. [Google Scholar] [CrossRef]
  252. Lai, D.C.; Nguyen, T.N.; Poonsuk, K.; McVey, D.S.; Vu, H.L. Lipid nanoparticle-encapsulated DNA vaccine encoding African swine fever virus p54 antigen elicits robust immune responses in pigs. Vet. Microbiol. 2025, 305, 110508. [Google Scholar] [CrossRef]
  253. Yuan, F.; Cui, J.; Wang, T.; Qin, J.; Jeon, J.H.; Ding, H.; Whittaker, C.A.; Xu, R.; Cao, H.; Chen, J. Selection, Design, and Immunogenicity Studies of ASFV Antigens for Subunit mRNA Cocktail Vaccines with Specific Immune Response Profiles. ACS Infect. Dis. 2025, 11, 1907–1921. [Google Scholar] [CrossRef]
  254. Hu, X.; Liu, C.; Rcheulishvili, N.; Wang, Y.; Xiong, T.; Xie, F.; Wang, X.; Chen, R.; Wang, P.G.; He, Y. Development and efficacy of a novel mRNA cocktail for the delivery of African swine fever virus antigens and induction of immune responses. Microbiol. Spectr. 2025, 13, e02909–e02924. [Google Scholar] [CrossRef]
  255. Kitamura, T.; Masujin, K.; Ikezawa, M.; Ambagala, A.; Kokuho, T. Generation of chimeric African swine fever viruses through in vitro and in vivo intergenotypic gene complementation. Vaccines 2025, 13, 462. [Google Scholar] [CrossRef]
  256. Abrams, C.C.; Goatley, L.; Fishbourne, E.; Chapman, D.; Cooke, L.; Oura, C.A.; Netherton, C.L.; Takamatsu, H.-H.; Dixon, L.K. Deletion of virulence associated genes from attenuated African swine fever virus isolate OUR T88/3 decreases its ability to protect against challenge with virulent virus. Virology 2013, 443, 99–105. [Google Scholar] [CrossRef]
  257. Sánchez-Cordón, P.J.; Chapman, D.; Jabbar, T.; Reis, A.L.; Goatley, L.; Netherton, C.L.; Taylor, G.; Montoya, M.; Dixon, L. Different routes and doses influence protection in pigs immunised with the naturally attenuated African swine fever virus isolate OURT88/3. Antivir. Res. 2017, 138, 1–8. [Google Scholar] [CrossRef]
Figure 1. Structure of the ASF virion with different layers and their proteins.
Figure 1. Structure of the ASF virion with different layers and their proteins.
Pathogens 15 00586 g001
Figure 2. Genomic structure of ASFV.
Figure 2. Genomic structure of ASFV.
Pathogens 15 00586 g002
Figure 3. Transmission dynamics of ASFV.
Figure 3. Transmission dynamics of ASFV.
Pathogens 15 00586 g003
Figure 4. Global distribution and outbreaks of ASFV from 1909 to 2026.
Figure 4. Global distribution and outbreaks of ASFV from 1909 to 2026.
Pathogens 15 00586 g004
Figure 5. Key determinants influencing the spread of ASFV in domestic pig herds.
Figure 5. Key determinants influencing the spread of ASFV in domestic pig herds.
Pathogens 15 00586 g005
Figure 6. ASFV prevention and control challenges.
Figure 6. ASFV prevention and control challenges.
Pathogens 15 00586 g006
Table 1. Different layers of the ASF virion with functions of constituent proteins.
Table 1. Different layers of the ASF virion with functions of constituent proteins.
Viral ComponentsGenomic Coding RegionProteins Involved in AssemblyFunctions and Features of the ProteinsReferences
Outer membrane/envelope061Rp12Aids in viral adsorption by facilitating the recognition of host cellular receptors through specific polypeptide binding and ensures virus entry into the host cell[22]
EP402RCD2vInteracts with sialic acid receptors on RBC surfaces, enabling infected cells to bind to them and accelerates hemadsorption[23]
KP177Rp22Unknown[24]
CapsidB646Lp72 (major capsid protein)Key antigen for serological diagnosis due to its antigenic stability and strong immunogenicity. It also plays role in morphogenesis, replication, and cellular transport[25,26]
B602LpB602L (chaperone of p72)This molecular chaperone assists correct folding and trimerization of p72 during capsid assembly[27]
H240RpH240REssential for virulence and pathogenicity, triggering infection-induced inflammatory responses[28,29]
M1249LpM1249LFunctions in immunomodulation[30]
D117Lp17Binds strongly to the p72 base domain, surrounding each p72 capsomer within the inner capsid shell. This strong binding anchors the virus to the inner membrane, which is crucial for its stability and viability. p17 is vital in capsid assembly and maturation[31,32]
E120Rp14.5Interacts with p72 and plays a crucial role in transporting mature virus virions from the viral factory to the host cell membrane, helping in virion release and subsequent host infection[33]
B438Lp49Plays an important role in morphogenesis, particularly in the formation of the icosahedral capsid vertices[34]
Inner membrane/
envelope
E183Lp54Enables viral entry into the perinuclear region by interacting and forming microtubule-based motor complexes. It also acts as a diagnostic antigen to detect antibodies of ASFV[35,36]
E248RpE248RRequired for virus–cell fusion, early infectivity, and viral core transfer to the cytoplasm[37]
H108RpH108RInteracts with capsid proteins p49 and p72 and helps in capsid assembly. It also has a regulatory role in ASFV morphogenesis. Deletion of pH108R reduces virus replication and attenuates ASFV virulence[38]
E199LpE199LNecessary for membrane fusion, viral uncoating, and viral core entry[39]
Core shellS273RpS273REssential for virion maturation and infectivity of the ASFV particle[40]
CP2475L (pp220 polyprotein)p150Highly immunogenic[22]
p37Aids viral entry and accumulation in the cytoplasm by facilitating transport between the nucleus and cytoplasm[6]
p34Highly conserved and immunogenic. It contains a T-cell epitope, indicating its potential to trigger a cell-mediated immune response. Mutations in the p34 are linked to replication and assembly of the ASFV virion[41]
p14Promotes nuclear transport activity by aiding virus replication[6]
p5Encodes a unique tryptic peptide covering 43% of its amino acid sequence[42]
CP530R (pp62 polyprotein)p15Interacts with other components during viral assembly and aids in the stabilization of the mature virus particles. It may also be involved in viral transcription and genome packaging by binding with dsDNA[43]
p35Serves as a docking scaffold, helping to recruit the host membrane and other components to the core shell, thus stabilizing the mature virion during assembly[4]
p8Low immunogenicity and rapid degradation[42]
Inner core/NucleoidA104RpA104R (histone-like protein)Induces DNA supercoiling and plays a role in genome packaging during virus assembly and virus evasion of host immunity[15,44,45]
K78Rp10It has a similar affinity for both dsDNA and ssDNA and supports viral replication, entry, and DNA packing[25,46,47]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Barua, S.; Gunawan, A.; Kayan, A.; Tenaya, M.; Cinar, M.U.; Kardena, M.; Akter, S.H.; Mat Isa, N.; Annandale, H.; Sarker, S.; et al. Current Insights into the Epidemiology and Transmission Dynamics of African Swine Fever Virus and Future Control Perspectives. Pathogens 2026, 15, 586. https://doi.org/10.3390/pathogens15060586

AMA Style

Barua S, Gunawan A, Kayan A, Tenaya M, Cinar MU, Kardena M, Akter SH, Mat Isa N, Annandale H, Sarker S, et al. Current Insights into the Epidemiology and Transmission Dynamics of African Swine Fever Virus and Future Control Perspectives. Pathogens. 2026; 15(6):586. https://doi.org/10.3390/pathogens15060586

Chicago/Turabian Style

Barua, Shanta, Asep Gunawan, Autchara Kayan, Masa Tenaya, Mehmet Ulas Cinar, Made Kardena, Syeda Hasina Akter, Nurulfiza Mat Isa, Henry Annandale, Subir Sarker, and et al. 2026. "Current Insights into the Epidemiology and Transmission Dynamics of African Swine Fever Virus and Future Control Perspectives" Pathogens 15, no. 6: 586. https://doi.org/10.3390/pathogens15060586

APA Style

Barua, S., Gunawan, A., Kayan, A., Tenaya, M., Cinar, M. U., Kardena, M., Akter, S. H., Mat Isa, N., Annandale, H., Sarker, S., Williams, D. T., Abraham, S., & Uddin, J. M. (2026). Current Insights into the Epidemiology and Transmission Dynamics of African Swine Fever Virus and Future Control Perspectives. Pathogens, 15(6), 586. https://doi.org/10.3390/pathogens15060586

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop